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MEASUREMENT OF RED BLOOD CELL OXYGENATION STATE BY 
MAGNETOPHORESIS 
NINA A. SMITH 
ABSTRACT 
 Magnetophoresis of red blood cells (RBCs) at varying partial pressures of oxygen 
(pO2) is hypothesized to rejuvenate stored blood to be utilized beyond the FDA regulated 
42-day storage time. Magnetophoresis is a particle or cells motion induced by an applied 
magnetic field in a viscous media. The average magnetophoretic mobility of an oxygenated 
RBC is -0.126x10-6 mm3-s/kg, and a deoxygenated RBC is 3.66x10-6 mm3-s/kg, presenting 
magnetophoresis as a resource for RBC rejuvenation in hopes of storing it longer than 42 
days. The main objective of this paper was to determine if controlling the pO2 within an 
RBC suspension, can singly- doubly- triply- or fully deoxygenated RBCs be identified by 
means of cell tracking velocimetry (CTV). These results agreed with the cooperative 
binding scheme developed by Hill, especially from ~30-40 to 160 mmHg. From 0 to 30 
mmHg, further research must be completed to characterize the binding behavior of oxygen 
and hemoglobin. The validation of the magnetic energy density gradient value (Sm, 
currently at 365 T-A/mm2) utilized within CTV, and the exact location for the field of view 
(FOV, currently set to 4.5 mm from the edge of the magnet assembly) were needed to state 
particle motion was independent of location within the CTV channel. The FOV location 
was successfully verified 4.5 mm from the edge of the magnet assembly, however, the Sm 
value, 880 T-A/mm2, was 140% higher than the original. Spectrophotometry was utilized 
to validate the oxygenation state of RBCs. Results confirmed spectrophotometry was a 
reliable model for RBC magnetophoresis. CTV post-processing was tested with glioma 
vii 
 
progenitor cells. Scatter plots generated for these experiments demonstrated cells with 
different magnetic mobilities in a sample can be detected. To fully characterize the glioma 
progenitor cells, more experiments must be completed. Lastly, applying a temperature 
gradient to the magnetic deposition microscopy (MDM) assembly to enhance the 
separation of RBCs was explored. Preliminary results determined, introducing a 
temperature gradient of 40°C was large enough to affect the RBC sedimentation rate in the 
channel. After, modeling within COMSOL was completed, however, more time and 
knowledge of COMSOL is needed to generate practical results.  
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Red blood cell (RBC) transfusions are needed by patients for a variety of reasons, 
such as to replace blood loss during a surgical procedure or trauma, or an illness which 
may cause anemia like liver disease, a hematological disease, or cancer (Why patients 
receive blood transfusions, 2019). A unit of RBCs is only able to be preserved and stored 
in a refrigerator for 42 days (Sparrow, 2010). The preservation solution most commonly 
utilized is saline-adenine-glucose-mannitol (SAG-M), which also extends the shelf-life of 
the RBCs (Sparrow, 2010). While stored, RBCs undergo physicochemical changes, which 
decreases the quality, function, and in vivo survival, due to being out of their natural 
environment (Sparrow, 2010). Depending on the storage duration of an RBC unit, there is 
a possibility that up to 25% of transfused RBCs clear from a recipient's circulation within 
24 hours (Moore, et al., 2018). As the need for a technique to separate fresh RBCs from 
aged RBCs arises, a possible solution is magnetic separation.  
As of 2002, magnetic separation has grown in the life sciences, particularly for cell 
separation (Zborowski, et al., 1995). As an RBC ages, it loses its ability to release oxygen 
(Haidas, et al., 1971), which in turn causes its magnetic properties to change (Pauling & 
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Coryell, 1936b), and it becomes more diamagnetic relative to water (Jin, et al., 2012). This 
will be described further in Section 2.1. This results in a difference in the magnetophoresis 
of aged RBCs compared to fresh RBCs, where magnetophoresis is defined as the particle 
motion created by an applied magnetic field within a viscous media (Zborowski, et al., 
2016). This magnetophoretic difference allows magnetic separation to be a feasible 
technique for isolating oxygen functional RBCs in stored blood from non-oxygen 
functional RBCs, to be utilized for transfusions. 
1.2 Hypothesis 
Based on previous studies, it is known that the magnetic susceptibility of RBCs 
changes at two oxygen partial pressure (pO2) extrema values of ~0 mmHg (high 
susceptibility) and ~160 mmHg (in ambient air, low susceptibility). Magnetic susceptibility 
of a material is defined as the response the material has to an applied magnetic field.  
However, the dependence of the RBC susceptibility on pO2 values between these two 
extremes was never studied. It is also known that the chemical kinetics of the oxygen 
binding to hemoglobin follows a cooperative binding model characterized by the Adair and 
Hill equations. With this information, it was hypothesized that the magnetic susceptibility 
of RBCs follows the same cooperative binding dependence on pO2. This hypothesis was 
made because it is known that the magnetic susceptibility of hemoglobin decreases linearly 
when the number of bound oxygen (O2) molecules to hemoglobin increases. In other words, 
we expect that RBC magnetophoresis depends on the oxygenation state of intracellular 
hemoglobin in a manner that is well understood theoretically, but has never been examined 
in detail experimentally. Therefore, under carefully controlled oxygenation conditions, the 
hypothesis was tested to determine if cell tracking velocimetry (CTV) is capable of 
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differentiating RBC subfractions differing in oxygenation state with sufficient accuracy. In 
turn, this would also determine if the dependence of RBC susceptibility on pO2 follows the 
cooperative binding model of Adair and Hill.  
1.3 Specific Aims 
To prove this hypothesis, a variety of experiments were performed.  
1. To determine the optimal magnetophoretic driving force vector, Sm, and the optimal 
field of view (FOV) location for cell tracking velocimetry (CTV) applications to 
study the magnetophoresis of red blood cells (RBCs). The optimal location of the 
FOV is where the Sm magnitude and the magnetic field-induced particle velocity 
does not depend on position inside the FOV. This will ensure the most accurate 
measurement of RBC velocities during deoxygenation experiments. These 
experiments were completed utilizing polystyrene (PS) particles within a 50/50 
mixture of Magnevist, which is a chelated and stabilized form of gadolinium, and 
a special buffer formulation with a defined magnetic susceptibility.  
2. To measure the absorbance of a blood sample to determine the methemoglobin 
(metHb) and oxyhemoglobin (oxyHb) concentration levels within it through 
spectrophotometry as a means to validate RBC deoxygenation. This technique was 
used to measure intraerythrocytic metHb concentration as the surrogate of 
deoxygenated RBCs. The data were analyzed with the equations stated in 
Winterbourne’s paper (Winterbourn, 1990) to determine the oxyHb, metHb, and 
hemichrome concentration levels within a metHb and oxyHb sample.  
3. To modify the CTV system to facilitate the deoxygenation of RBCs for 
magnetophoresis experiments. The system modifications allowed for precisely 
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controlled deoxygenation of RBCs while their magnetophoretic motion was 
analyzed by CTV. 
4. To measure the magnetophoretic mobility of RBCs at varying oxygenation levels, 
to study the effect of O2 binding to hemoglobin (Hb-O2) on red blood cell 
magnetization. The Hb-O2 reaction kinetics is known from Hb-O2 equilibrium 
curves determined spectrophotometrically, however, spectrophotometry of the bulk 
sample does not provide details about the cooperative binding process. The purpose 
of this study was to determine if RBC magnetophoresis as a function of Hb-O2 
binding could provide details about individual stages of a cooperative binding.  
5. To validate CTV data post-processing capabilities using the model of glioma 
progenitor cells known for atypical iron metabolism and to compare their magnetic 
velocities with the magnetic velocities of oxygenated and deoxygenated RBCs. 
These experiments were used to validate the sensitivity of CTV to distinguish 
differences in magnetic velocities of different cell types other than RBCs, such as 
3T3, GL26, and GL261 cell lines. The CTV data was analyzed by a newly 
developed MATLAB code.  
6. To model and explore the effects of convective transport with a temperature 
gradient as a possible option to enhance RBC magnetic separation. This would 
determine if convective transport heightened by a temperature gradient is a feasible 
approach to high throughput RBC separation. Modeling within COMSOL was 
briefly explored to determine if cooling the MDM magnet to 0°C and heating the 




1.4 Significance of Research 
The significance of this research is in its contribution to understanding the physical 
processes associated with stored blood aging, with potential applications to stored blood 
“rejuvenation,” so that blood could be safely used beyond the current limit of 42 days. 
Specifically, this study investigates how the oxygen concentration in solution influences 
the magnetic field-induced velocity of an RBC in suspension. The accumulation of oxygen 
binding defects in RBCs over the blood storage time contributes to the current limit of 42 
days. Such defects have been shown within Dr. Maciej Zborowski’s laboratory at the 
Cleveland Clinic, the site of this research, and by collaborators, to affect the magnetically 
induced RBC velocity, which therefore could provide a basis for selective depletion of the 
non-functional RBCs. This research contributes to the future design of a magnetic RBC 
sorter that could improve the quality of stored blood and therefore extend the storage time 











2.1 Red Blood Cell Properties 
 A general understanding of the biology of an RBC is needed before proceeding 
with the experiments described in Chapter I. About 270 million hemoglobin molecules are 
present within a mature RBC, accounting for approximately 90% of an RBC’s dry weight 
(D'Alessandro, et al., 2017). For every hemoglobin molecule there are four folded globin 
proteins, two beta chains and two alpha chains, each containing its own heme group, which 
is a red pigmented molecule with the capabilities of binding to an iron ion (Fe2+, ferrous) 
(Erythrocytes, 2013). Figure 1 represents what a single hemoglobin molecule looks like 
within an RBC. Every Fe2+ is able to bind to one oxygen (O2) molecule, therefore, each 
hemoglobin has the capacity to carry four O2 molecules. The binding sequence of O2 to 




Figure 1: Structure of a single hemoglobin molecule within an RBC containing four folded globin proteins, two alpha and 
two beta chains, each connected to heme groups which carry an iron ion (Mader, 1997). 
 
 
Figure 2: Schematic representation of cooperative mechanism of O2 binding to Fe2+ within hemoglobin (Hemoglobin: 
portrait of a protein in action , 2012). The open circles illustrate the tetrameric structure of the hemoglobin molecule. Each 
monomer binds one O2 molecule sequentially when the pO2 increases from zero on the left to fully saturated at the ambient 
pO2 of approximately 160 mmHg, on the right. The arrows indicate that the bound O2 increases the hemoglobin tetramer 
affinity to bind to O2, a mechanism known as “cooperative binding”. 
  
The electron configuration of the Fe2+ bound to the hemoglobin causes an RBC to 
be paramagnetic. When an O2 molecule is bound to a Fe
2+ ion the hemoglobin is 
diamagnetic. Unpaired electrons within the four heme groups of a deoxyhemoglobin 
(deoxyHb) is what causes the RBC to present paramagnetic properties as contrasted by the 
diamagnetic character of oxyhemoglobin (Zborowski, et al., 2003). As presented in Figure 
3, the ferrous molecule contains two free electrons due to the ionic bonding, and when O2 
is bound to the globin protein, the unpaired electrons are bound, creating a covalent bond 




Figure 3: Left: Shows the ionic bonds between the ferrous molecule and globin protein. Right: Demonstrates the 
configuration change when O2 is bound in resonating structures (Pauling & Coryell, 1936a). 
 
2.2 General Magnetic Properties 
There are four types of magnetization: diamagnetism, paramagnetism, 
ferromagnetism, and superparamagnetism. For the scope of this paper, only diamagnetism 
and paramagnetism will be analyzed for experiments, and ferromagnetism will be used to 
understand how permanent magnets are utilized. For more information on 
superparamagnetism, refer to ‘Introduction to Magnetic Materials’ (Cullity & Graham, 
2008), ‘Four Different Types of Magnetism’ (Four different kinds of magnetism, 2016), 
and ‘Magnetic Cell Separation’ (Zborowski & Chalmers, 2007). When a particle is 
diamagnetic, it is repelled from a magnetic field source. It is an extremely weak form of 
magnetism that is only observed when an external magnetic field is present.  However, a 
paramagnetic particle is weakly attracted to a magnetic field source. For example, the four 
heme groups of deoxy and metHb (chemically reduced red blood cell, surrogate for deoxy 
red blood cells) have unpaired electrons, which gives them paramagnetic properties 
(Zborowski, et al., 2003). 
To appreciate how permanent magnets in devices perform, the fundamental theory 
and equations of magnetics and ferromagnetism is needed. The first property which is vital 
to recognize is that all magnetic fields are the result of electrons in motion (Understanding 
permanent magnets, 2015). For example, Figure 4 displays an iron atom that has an 
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imbalance in the spin direction of electrons, allowing them to be transferred to and from 
the atom, or to and from a spin direction, which creates an atomic magnetic dipole moment 
(pm) within the atom (Understanding permanent magnets, 2015). The magnetic dipole 
moment is a microscopic property of the material measured in A-m2. (Campbell, 1999). 
Within a current loop, it can be calculated from the following equation: 
𝑝𝑚 = IA  (2.1) 
 
where I is the current within the loop and A is the surface area bounded by the current I, 
which is coincident with the path of I. Vector quantities within equations are represented 
by bold notation. 
 
Figure 4: Imbalance of electrons within an iron atom’s electron shells (Understanding permanent magnets, 2015). 
 
The magnetic dipole moment vector produced when electrons are coordinated 
between neighboring atoms through cooperative interatomic exchange forces, determines 
the ability of a material to create spontaneous magnetization and become a source of the 
magnetic field in space around that material (known as a permanent magnet). The magnetic 
field strength, denoted as H, and is measured in ampere-turns per meter in the International 
System (SI), or in oersteds (Oe) in the gram-centimeter-second (CGS) system (Permanent 
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magnet guidelines, 1998). Another description of H is depicted in Figure 5, where a 
current, I, was produced by a DC battery to flow through wires to a load. The movement 
of electrons in the conductor, also known as the current flow, causes a magnetic field to be 
established around the wire (Understanding permanent magnets, 2015). For example, an 
infinitely long solenoid produces an H field inside the solenoid, which can be calculated 
by Equation 2.2 (Cullity & Graham, 2008). 
H = nI1  (2.2) 
 
Here n is the number of turns per unit length (in units of 1/m) and I1 is the current in the 
conductor (measured in amperes, A). 
 
Figure 5: Current flow within a coil resulting in a magnetic field (Understanding permanent magnets, 2015). 
 
When a paramagnetic substance is placed inside the coil, a magnetic field is 
induced, which increases the total observed field. The magnitude of the magnetic field per 
unit area is known as the flux density and is measured normal to the direction of 
magnetization (Permanent magnet guidelines, 1998). The flux density is denoted as B and 
is measured in the CGS system as “lines” of magnetic flux, or maxwells per square 
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centimeter, (one maxwell per square centimeter is equal to one gauss), while in the SI 
system, it is measured in tesla (one tesla, T is equal to one weber per square meter, Wb/m2) 
(Understanding permanent magnets, 2015). Equation 2.3 demonstrates that B is directly 
proportional to H within a vacuum (free space). 
𝑩 = 𝜇0𝑯 (2.3) 
 
Magnetic permeability of free space is represented by µ0. It is a constant fixed by the 
definition of the electric current unit, µ0 = 4π10
-7 T-m/A (Zborowski & Chalmers, 2007). 
 Once H and B are known for a magnetic material, a normal magnetization curve 
and a hysteresis loop can be generated. The normal magnetization curve is simply the 
induced flux density, B, versus the magnetizing field, H. A hysteresis loop is a more 
complex curve because it demonstrates how a magnetic material reacts when an external 
magnetic field is applied to it. To produce the loop, a sample material is placed between 
the poles of an electromagnet, leaving a minimal air gap between the sample and the poles 
(Understanding permanent magnets, 2015). Figure 6 depicts a normal hysteresis loop and 
an intrinsic hysteresis loop. The difference between a normal and an intrinsic hysteresis 
loop is the normal hysteresis loop compares B versus H, while the intrinsic loop compares 
magnetization (J, which is described below) versus H. For permanent magnets, the first 
quadrant is analyzed to learn how difficult it might be to magnetize a material to saturation 
(What is the magnetic hysteresis loop, 2015). The first quadrant also corresponds to the 




Figure 6: Normal and intrinsic hysteresis loops with key properties marked (What is the magnetic hysteresis loop, 2015). 
 
To obtain a permanent magnet, a magnetic material must be able to sustain a 
magnetic flux without the presence of a coil, or outside source, which is known as a 
ferrimagnet. To achieve this, exchange interaction must occur, which is the alignment of 
the magnetic dipole’s axes due to the materials own internal field (Campbell, 1999). 
Because an internal field exists without the presence of an applied external field, the 
material is spontaneously magnetized (Campbell, 1999). When a flux density is produced 
by a magnet alone it is called an intrinsic induction, magnetization (M), or magnetic 
polarization (J) (units of A/m) (Understanding permanent magnets, 2015). 
Magnetization yields a specific value in a designated volume of a magnet, however, 
it is not likely the entire magnet will present the same, unique M throughout the material 
(Campbell, 1999). Magnetization is the sum of the magnetic dipoles, pm, over the volume, 
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V, shown in Equation 2.4. The description provided thus far neglects the practical 
conditions which occur, such as temperature variation which would disrupt the alignment 
of the moments and reduce the materials magnetization (Campbell, 1999). By rearranging 
Equation 2.4, the overall magnetic dipole moment, P, is equivalent to the magnetization 
multiplied by the volume of the substance being measured, shown in Equation 2.5. From 
the magnetic dipole moment, the magnetic force exerted, denoted by F, is able to be 
calculated from Equation 2.6. Here dB0/dx is the derivative of the flux density over the 
















One way to characterize a material within a magnetic field would be to determine 
the magnetic susceptibility of the material. Volumetric, magnetic susceptibility, denoted as 
χ, is a dimensionless material property, which measures the response of a material to an 
applied magnetic field (Borradaile, 1998), defined by Equation 2.7. To convert χ from CGS 
units to SI units, it must be multiplied by 4π as shown in Equation 2.8. The conversion 
factors from CGS to SI units for the mass, specific, molar, and one-gram-formula-weight 
susceptibilities with their units in CGS and SI are included in Appendix A, Table X. The 
magnetic susceptibility is determined experimentally by measuring the amount of force 
exerted by a well-defined magnetic field on an established volume of a substance 
(Zborowski & Chalmers, 2007). The magnetic force exerted can also be calculated from 
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Equation 2.9, by rearranging Equation 2.7 to replace M, where H is the magnetic field 













Faraday designed an experiment utilizing a balance to measure the magnetic 
susceptibility of different materials, which is shown in Figure 7. Part A in Figure 7 
demonstrates how a paramagnetic, or ferromagnetic, material would react when placed on 
the left side of the balance. Due to the magnetic field, the material would be attracted to 
the field, which would mean the magnetic susceptibility of that material was greater than 
zero (χ>0). Therefore, weight would need to be added to the opposite side to keep the 
balance at equilibrium, and to keep the material from being pulled into the magnetic field. 
However, for a diamagnetic material, it would repel out of the magnetic field causing the 
magnetic susceptibility to be less than zero (χ<0). Therefore, as shown in Part B of Figure 
7, weight would be added to the side with the material being tested to keep the balance at 
equilibrium. 
 
Figure 7: Schematic of Faraday’s magnetic balance used to determine the magnetic susceptibility of different materials 
(Zborowski & Chalmers, 2007). 
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2.3 Magnetic Susceptibility Balance 
The modern-day Faraday balance, which employs the Gouy technique, is known as 
a magnetic susceptibility balance (MSB). A schematic of the Gouy balance is shown in 
Figure 8. This technique utilizes an electromagnet and a conventional balance. When a 
sample is placed between the magnet poles, it will appear to gain weight (be attracted to 
the magnet) or lose weight (be repelled from the magnet) (Magnetic susceptibility balances, 
1930). As described by the Faraday balance, weight gain indicates the sample would be 
ferro- or paramagnetic, while weight loss indicates a diamagnetic sample.  
 
Figure 8: Adapted schematic of a traditional Gouy balance (Magnetic susceptibility balances, 1930). 
 
An MSB operates with similar techniques to the Gouy balance, however, the 
sample remains stationary while the magnets within the system move. Figure 9 displays a 
schematic of the inside of an MSB with an image of an actual balance below it. A pair of 
magnets are on opposite sides of the beam, which creates a balanced system with a 
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magnetic field on each end (Magnetic susceptibility balances (MSB), 2005). Once the 
sample is introduced into the magnetic field, it attempts to deflect the set of magnets closest 
to it on the beam (Magnetic susceptibility balances, 1930). This movement is detected by 
the optical sensors, which passes a current through a coil between the other pair of magnet 
poles to produce an equal and opposite force that was exerted by the sample to return the 
system to an equilibrium position (Magnetic susceptibility balances (MSB), 2005). Thus, 
the current through the coil is proportional to the force exerted by the sample, and the 
direction in which the beam moves indicates if the sample is paramagnetic (shown by a 
plus sign on the display) or diamagnetic (shown by a minus sign on the display) (Magnetic 




Figure 9: Above: Schematic of the inside of an MSB (Magnetic susceptibility balances (MSB), 2005). Below: Image of 
the actual MSB-Auto from Dr. Zborowski’s lab at the Cleveland Clinic. 
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2.4 Magnetic Separation of Labeled versus Unlabeled Cells 
 Magnetically labeling cells is one way magnetics is employed to separate specific 
cells to be utilized for treatments and/or analyzed for a prognosis of a disease (Joshi, et al., 
2014). Biological materials have low magnetic susceptibility. To increase the highly 
selective magnetostatic forces, cells are tagged with magnetic nanoparticles, which do not 
interfere with the physiological electrolyte solutions used for cell suspensions and with 
other cells (Zborowski, et al., 2016). However, based on a biological cell’s intrinsic 
magnetic properties, labeling with magnetic nanoparticles may not be necessary, provided 
the magnetic device yields a high enough magnetic field. This is an attractive alternative 
to techniques which rely on immunomagnetic labeling because it eliminates the cost of 
reagents and the arduous sample preparation steps of labeling the particles (Jin, et al., 
2012).  Intraerythrocytic malaria parasites (Zimmerman, et al., 2006) and select cancer cell 
lines have been tested and used to demonstrate the feasibility of magnetophoresis and 
magnetic separation by the means of only their intrinsic magnetic susceptibility (Joshi, et 
al., 2015). These types of cell separation were quantified by enrichment upon separation. 
For example, Plasmodium malariae infected erythrocytes were enriched from 0.4% to 
100% by means of magnetic deposition microscopy (MDM) (Zimmerman, et al., 2006). 
Other examples are RBCs, which do not require magnetic nanoparticle labeling due to the 
presence of unbound electrons (Zborowski, et al., 2003) creating a magnetic dipole 
moment, and glioma brain cancer progenitor cells because of the increased ferritin uptake 
which takes place by these cells (Kawabata, et al., 1999). In the following sections, 
separation and analytical devices are presented to demonstrate how to evaluate the 
magnetic susceptibility of labeled or unlabeled cells. 
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2.5 Separation Devices 
 Magnetic cell separation and manipulation has a large impact on the development 
of biotechnology engineering and is one of the fastest growing segments of cell separation 
(Zborowski, et al., 2016). Two examples of high-gradient magnetic separation (HGMS) 
devices are the quadrupole magnetic cell sorter (QMS) and the circular Halbach array. 
These magnet arrangements are excellent tools for quantifying purity, recovery, and 
throughput of sorted cell fractions. They can be utilized to separate red blood cells from 
whole blood and separating cells which were magnetically labeled. ‘Continuous, intrinsic 
magnetic depletion of erythrocytes from whole blood with a quadrupole magnet and 
annular flow channel; pilot scale study’ (Moore, et al., 2018) and ‘Circular Halbach array 
for fast magnetic separation of hyaluronan-expressing tissue progenitors’ (Joshi, et al., 
2015) provide more information on these devices.  
2.6 Analytical Devices 
 There are numerous magnetic devices which are used to quantify the 
magnetophoretic mobility (described further in Section 2.6.1) of cells, such as cell tracking 
velocimetry (CTV), magnetic deposition microscopy (MDM), and magnetic flow-field 
fractionation (MgFFF). Through CTV, cells are tracked with the computer program, 
ImageView (described further in Section 3.4.4), to determine the average magnetic and 
average sedimentation velocities of a sample. With MDM, a sample is infused into a 
channel, which is placed on to a magnetic assembly, allowing the magnetic cells to deposit 
on a Mylar slide and the nonmagnetic cells continue to the outlet of the channel. Lastly, 
MgFFF separates cells based on different levels of magnetic material on, or within them, 
and passes the fractions to an analytical device, such as a mass spectrometer. For more 
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information on MgFFF refer to ‘Characterization of magnetic nanoparticles using 
programmed quadrupole magnetic field-flow fractionation’ (Williams, et al., 2010).  
2.6.1 Cell Tracking Velocimetry 
 An increasingly important technique for the diagnosis and treatment of various 
cancers and diseases is cell analysis and separation (Zborowski, M., Chalmers, J., & 
Moore, L. R., 2003). To help with analysis, cell tracking velocimetry (CTV) was patented 
by Dr. Maciej Zborowski, Dr. Jeffrey J. Chalmers, and Lee Moore in July of 2003 
(Zborowski, M., Chalmers, J., & Moore, L. R., 2003). The technique measures a labeled 
or unlabeled particle’s magnetically induced velocity when placed in a magnetic field and 
its settling velocity, by means of video imaging through CTV. From the settling velocity, 
the size of the particle can be calculated.  
There are three fundamental components along with theoretical concepts needed 
for CTV. The three characteristics are a well-characterized magnetic field energy gradient, 
a microscopic image acquisition system, and a computer algorithm particle tracking 
velocimetry (PTV). With PTV the location and velocity of a particle can be determined in 
the region of image analysis (Nakamura, et al., 2001). To begin the theoretical analysis, 
the forces which act on the particle during CTV must be identified: the magnetic force 
(Fm), the buoyant force (Fb), the viscous drag force (Fd), and force by gravity (Fg). From 
these forces, the magnetic velocity, settling velocity, and the hydrodynamic diameter of the 
particle can be determined.  
Equation 2.10 demonstrates the magnetic force, Fm, depends upon three variables: 
Sm (calculated from measured data), Δχ (determined from previous experiments or 
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literature), and Vp, which is the volume of the particle within the sample (known by 
researcher making sample) (Nakamura, et al., 2001).  
𝐹𝑚 = ∆𝜒𝑉𝑝𝑆𝑚 (2.10) 
 
The magnetophoretic driving force, Sm, is defined by Equation 2.11, where H and B are 
known from the calibration of the CTV magnet, and µ0 is the magnetic permeability 
constant. 
















The Δχ (dimensionless) is the difference between two solutions volumetric, magnetic 
susceptibility calculated by Equation 2.12, which is written for the two solutions utilized 
in the Sm verification experiments. This equation
 could also be used to determine the 
magnetic susceptibility difference between a particle and a solution, where the solution 
susceptibility would be subtracted from the particle’s susceptibility. 
Δ𝜒 =  𝜑𝑀𝑎𝑔𝑛𝑒𝑣𝑖𝑠𝑡𝜒𝑀𝑎𝑔𝑛𝑒𝑣𝑖𝑠𝑡 −  𝜑𝐻2𝑂𝜒𝐻2𝑂 (2.12) 
 
The ϕMagnevist is the volume fraction of Magnevist (known by researcher creating the 
solution), χMagnevist is the volumetric, magnetic susceptibility of the Magnevist (physical 
property of substance), ϕH2O is the volume fraction of water (known by researcher creating 
the solution), and χH2O is the volumetric, magnetic susceptibility of water (physical 
property of substance). The difference between the magnitude of the buoyant force, Fb,, 
and the gravity force, Fg, is defined as follows (Nakamura, et al., 2001):  
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where ρp is the density of the particle, ρf is the density of the fluid, Dp is the particle 
diameter, and g is the gravity constant, which are all known from literature. Lastly, when 
the Reynold’s number is less than 0.1 the viscous drag force can be assumed to be the 
Stokes drag (Nakamura, et al., 2001). 
𝐹𝑑,𝑥 = 3𝜋𝐷𝑝𝜂𝑢𝑚 (2.14) 
 
Here Fd,x is the drag force component opposing the particle motion in the um direction, 
where um is the terminal magnetic velocity component in the horizontal direction (directly 
measured), Dp is the particle diameter, and η is the viscosity of the fluid (known from 









where Equation 2.12 was used to calculate Δχ between two materials.  
  The particle terminal velocity is calculated by equating the total force, F, with the 
viscous drag force (Xue, et al., 2019): 
𝐹 = 𝐹𝑑 (2.16) 
where F is also the vector sum of the magnetic component, Fm, (acting in the horizontal, 
x-axis direction) and the Fg – Fb component (acting in the vertical, y-axis direction), so that 
in the vertical direction the following expression for the drag force applies:  
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𝐹𝑑,𝑦 = 3𝜋𝐷𝑝𝜂𝑣 (2.17) 
 
The particle terminal velocity vector has two components, in the horizontal (x-axis) 
direction and vertical (y-axis) direction. From the foregoing equations, terminal velocity 












2 𝑔 (2.19) 
where um is the experimentally determined mean magnetic velocity in units of m/s, v is the 
experimentally determined sedimentation velocity in units of m/s, and the other variables 
follow the same notation stated within this section. The particle magnetophoretic mobility, 
m, is defined as the ratio of its magnetic field-induced velocity, um, and the 





These equations provide the theoretical foundation for CTV. 
The well-defined magnet assembly, Mk V, which has been utilized in many other 
experiments, is the strongest magnet created for CTV research (Xue, et al., 2019). Within 
the FOV, the magnetostatic potential energy gradient, Sm, is horizontal, nearly constant, 
and well-characterized due to the hyperbolic pole pieces within the system, which occurs 
in the microscopes FOV (Xue, et al., 2019). Figure 10 Part A represents the section of the 
CTV system where the cell suspension is contained by a glass channel, which is located 
inside the magnet assembly (Xue, et al., 2019). The magnetostatic potential energy density 
gradient should be as constant as possible to avoid any variation in the magnetic field 
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presented to the particles within the FOV. Figure 11 represents a predicted model of the 
Mk V magnet flux density field B in units of Tesla (T) (blue dotted line), with a best fit 
line corresponding to the flux density (black line), the gradient of the B field (red line), and 
twice the product of the magnetic flux density field and the gradient of the flux density, 
dB2/dy (green line), which is proportional to Sm. Here the Sm graph is nearly constant within 
the FOV, which would allow for the particles to be exposed to the most uniform magnetic 
field possible. This is important in order to characterize the magnetic properties of the 
particles appropriately within the CTV system. If the magnetic field within the FOV is 
constant, or nearly constant, the particles will have a magnetic velocity which is 
independent of the particle location within the system.  
 
Figure 10: Image of the CTV magnet with explanations. A) Photograph of portion of permanent magnet showing 
hyperbolic shape of pole pieces with the glass channel colored red, B) Composite diagram of equipotential and field lines 
(top) and magnetostatic potential isolines and force vectors (bottom) C) Expected outcomes for deoxygenated RBCs (top) 





Figure 11: Key CTV magnetostatic field parameters (Xue, et al., 2019). 
 
The computer algorithm needed to perform CTV mentioned above originated from 
a 3-D version of particle tracking code, known as particle tracking velocimetry (PTV) 
(Nakamura, et al., 2001). PTV utilized five successive images to predict the most probable 
pathway for a specific particle (Nakamura, et al., 2001). The original PTV algorithm was 
developed for 3-D flow visualization studies of complex hydrodynamic flow where 
hundreds of instantaneous velocities at different locations were wanted, and does not report 
particles tracked from frame to frame (Nakamura, et al., 2001). For CTV, the algorithm 
was modified to provide these reports in which the location and velocities of specific 
particles are presented for a series of frames, which is determined by the user (Nakamura, 
et al., 2001). This algorithm will be described in length in Chapter III – Materials and 
Methods. 
2.6.2 Magnetic Deposition Microscopy 
 Magnetic cell separation was propelled to the forefront of separation techniques 
due to the rapidly growing demands in cell biology and clinical laboratories (Zborowski, 
26 
 
et al., 2016). The prototype of MDM was known as the Bio-Ferrograph, which was 
developed in collaboration with the Institute Guilfoyle in Belmont, MA and Bingbing 
Fang, Dr. Maciej Zborowski, and Lee Moore from the Department of Biomedical 
Engineering at the Cleveland Clinic (Fang, et al., 1999). A few of the first cell-types 
separated utilizing MDM (Bio-Ferrograph) were MCF-7 breast cancer cells and malaria 
cells from whole blood.  
 Applications of MDM are known to pull weakly magnetic cells from a flowing cell 
suspension due to the high magnetic gradient generated by the magnets within the 
assembly. The magnetic cells are deposited onto a transparent, thin sheet of Mylar, which 
can be analyzed under a microscope. More information about the magnet assembly can be 
found in ‘Magnetic separation of algae genetically modified for increased intracellular iron 
uptake’ (Buck, et al., 2014).  
 A theoretical analysis of the MDM is similar to CTV because the magnetic force, 
the viscous drag force, and the magnetic velocity are calculated from the same equations, 
Equation 2.10, 2.14, and 2.18, respectively (Moore L. R., et al., 1998). However, the 
microfluidic fluid velocity profile between CTV and MDM are different. The following 
equation approximates the velocity profile given by Purday (Moore L. R., et al., 1998): 










) ;         |𝑥| ≤ 𝑎, |𝑦| ≤ 𝑏 (2.21) 
 
The cell velocity is represented by w, wmax is the maximum cell velocity, x and y are 
distances from the channel center, a is the half-depth of the channel, b is the half-width of 
the channel, and n is a constant that depends on the aspect ratio of the channel, b/a. It can 
be calculated by Equation 2.22 (Moore L. R., et al., 1998). 
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Once n is known, the relationship between wmean and wmax can be determined by Equation 













Here Qo is the volumetric flow rate entering the channel and A is the surface area of the 
channel.  
Below, Figure 12 provides three important aspects to the MDM setup. Part A 
displays a color map, with graduations of 0.08 T, of the magnetic field generated by the 
magnetic assembly (Buck, et al., 2014). At the edges of the two interpolar gaps, the blue 
rectangles, there are four spots where the magnetic field exceeds 1.4 T and the gradient 
exceeds 1,000 T/m, at the corners of the interpolar gaps (Buck, et al., 2014). Part B presents 
a graph which verified the field map compared to the magnitude of the magnetic field along 
the y-axis at x=0 (Buck, et al., 2014). The last part of Figure 12 is Part C, which represents 
all the components of the experimental setup. The magnet assembly is labeled 1, the Mylar 
slide is denoted as 2, while 3 is the silicon rubber gasket with five flow channel cutouts, 4 
is the manifold with the inlet at the bottom connected to the sample vial by tubing and the 
outlet at the top linked to the syringe pump also by tubing, and lastly 5 is the platen which 
holds all of the parts together against the magnet (Buck, et al., 2014). Figure 13 is an image 





Figure 12: (A) Color map of the magnetic field with color graduations of 0.08 T, (B) Verified the magnitude of the 
magnetic field represented by the color map in A along the y-axis with x=0, (C) Represents all of the parts used to 





Figure 13: 1) 1 mL vials containing sample solutions. 2) Microfluidic tubing connecting the sample to the channel against 
the magnet. 3) Fully assembled MDM system presented in Part C in Figure 12 along the y-axis. 4) Second set of 
microfluidic tubing connecting the channel to the syringes. 5) Three-way Hamilton valves allowing the sample to move 
from the channel to the syringes. 6) 1 mL syringes collecting the sample solution. 7) Legato 210P multi-syringe kd 




2.7 Cooperative Binding of Oxygen and Hemoglobin: Adair and Hill Equations  
 Red blood cell saturation by oxygen depends on the pO2 in the solution and is 
described by Adair’s equation illustrated by the oxygen-hemoglobin equilibrium curve in 
Figure 14. This is also demonstrated in Figure 15, where fully oxygenated RBCs (low spin) 
present a diamagnetic magnetic mobility, whereas fully deoxygenated RBCs (high spin) 
display a more paramagnetic response in the presence of a magnetic field (Zborowski, et 
al., 2003). The number of cells tracked is denoted by n, and magnetic mobility is denoted 
by m.  
 
Figure 14: Graph of the oxygen-hemoglobin equilibrium curve generated in Maple by Dr. Zborowski. Graph of the 
fractional concentrations of five hemoglobin-O2 complexes (left axis), and the corresponding hemoglobin-O2 equilibrium 
curve (right axis) as a function of pO2 calculated from the Adair equation. Symbols nB describe the number of heme 





Figure 15: Magnetophoretic mobility of oxygenated and deoxygenated RBCs. The graph on the left represents fully 
oxygenated RBCs, while the graph on the right displays fully deoxygenated RBCs (Zborowski, et al., 2003). 
 
Adair’s generalized equation is stated in Equation 2.25, where S is the fractional saturation, 
p is the oxygen pressure, an are the overall Adair parameters, which are determined 
experimentally, and n corresponds to the number of oxygen molecules bound to the 
hemoglobin within the RBCs (Winslow, et al., 1977). The Kn parameters are the stepwise 
Adair constants, which refer to a specific binding scheme of oxygen to hemoglobin and the 
simplest way to describe the binding scheme (Imai, 1994). Theoretical values for the 












1 + 4𝐾1𝑝 + 6𝐾1𝐾2𝑝2 + 4𝐾1𝐾2𝐾3𝑝3 + 𝐾1𝐾2𝐾3𝐾4𝑝4)
 
(2.25) 
Also, S is the fractional saturation of oxyhemoglobin, which influences RBC 
magnetophoresis by determining the magnetic susceptibly of an RBC. Equation 2.26 
demonstrates how the fractional saturation levels influence the susceptibility of an RBC.  
𝜒𝑅𝐵𝐶 = 𝜑H2O𝜒H2O + (1 − 𝑆)𝜑Hb𝜒deoxyHb + 𝜑globin𝜒globin (2.26) 
The volume fraction of water, deoxyhemoglobin, and the globin protein are denoted as 
ϕH2O, ϕHb, and ϕglobin, respectively. The volumetric, magnetic susceptibility of these species 
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are χH2O for water, χdeoxyHb for deoxyhemoglobin, and χglobin for the globin protein. Utilizing 
these definitions, varying the fractional saturation of the RBC solution, and evaluating the 
volumetric, magnetic susceptibility at those fractional saturation values by means of the 
CTV deoxygenation system, it will be determined if the oxygenation level of an RBC can 
be measured through magnetophoresis. 
Table I: Form-specific Adair’s Coefficients (Matejak, et al., 2015). 
Estimated Form-Specific Adair’s Coefficients 










The Hill equation, stated in Equation 2.27, was originally formulated by Archibald 
Hill in 1910 to describe the sigmoidal curve of oxygen binding to hemoglobin (Hill, 1910). 
Here Y is the fractional saturation of oxygen bound to the hemoglobin, x corresponds to the 
log of the Gaussian b-value, k is 10 raised to the negative value of the y-intercept from the 
regression line of the linearized Hill equation, and n is the Hill coefficient, also known as 
the slope of the regression line of the linearized Hill equation. This will be discussed further 
in Section 3.4.6. For the purpose of this study, the Hill equation was considered a 
satisfactory approximation of a more complex Adair equation in applications to analyze 
the RBC magnetophoresis data. 









 There are many applications within the life sciences for spectrophotometry outside 
of a classroom. For example, it could be used to determine the number of cells within a 
suspension. For the interest of the research being presented in this paper, it was utilized to 
determine the concentration of oxyhemoglobin and methemoglobin within a blood sample. 
This is done by measuring the amount of light which passes through or is absorbed by a 
sample (Bostick, 2018). Spectrophotometry follows two basic principles. First, every 
substance transmits or absorbs specific wavelengths of energy (Bostick, 2018). Second, 
depending on the amount of material dissolved within the sample solution (known as an 
analyte), the measured intensity of the color will vary, allowing the concentration of a 
substance to be determined within the sample (Bostick, 2018). Figure 16 represents a 
general overview of what occurs within a spectrophotometer. An initial known intensity of 
light, I0, is passed through the sample, and a different intensity, I, is measured by the 
photocell on the opposite side of where the initial light entered the sample. Equation 2.28 
is then utilized to calculate the transmittance of the sample, T. 
 









Another way to interpret the intensity of light within a sample is with the absorbance, A. 
This value can be calculated with Equation 2.29. 
𝐴 =  − 𝑙𝑜𝑔 𝑇 
(2.29) 
 Christine Winterbourn determined that different forms of oxygen-hemoglobin 
compounds present different absorbance levels when a spectrum of 500 – 700 nm 
wavelengths are passed through the sample (Winterbourn, 1990). Specifically, 
Winterbourn focused on oxyhemoglobin, methemoglobin, and hemichrome. 
Oxyhemoglobin (oxyHb) is the form of hemoglobin where all eligible binding sites of the 
hemoglobin molecule have an O2 molecule bound, therefore, there are no unpaired 
electrons. Methemoglobin (metHb) is formed by chemically reducing oxyHb with sodium 
nitrite (NaNO2). Hemichromes form by methemoglobin having an unstable globin 
structure, which allows for the distal histidine or an external ligand to bind to heme 
(Winterbourn, 1990). Chemical reactions presented in Equations 2.30 and 2.31 represent 
how oxyHb turn into metHb and metHb revert to oxyHb, respectively.  
2H∓ + O2
− + oxyHb → metHb + O2 + H2O2 (2.30) 
 
O2
− + metHb → oxyHb + 2𝑒− (2.31) 
It is known that reactions can be followed spectrally, and with this information 
Winterbourn developed equations to calculate the concentration, in units of µM, of 
oxyhemoglobin, methemoglobin, and hemichrome within a blood sample, presented in 
Equations 2.32, 2.33, and 2.34, respectively. The Ai variables denote the absorbance value 
at the i wavelength. 




[Methemoglobin] = 28𝐴577 + 307𝐴630 − 55𝐴560 (2.33) 
 
[Hemichrome] = −133𝐴577 − 114𝐴630 + 233𝐴560 (2.34) 
 
At each of these absorbance levels there are certain attributes which allowed for a 
distinction between the different hemoglobin types. For wavelength 577 nm, oxyHb 
presents a sharp rise to a second peak (Winterbourn, 1990). MetHb presents a characteristic 
peak or shoulder at wavelength 630 nm (Winterbourn, 1990). Lastly, hemichrome is shown 
by a shallower trough at 560 nm within oxyHb-metHb mixtures (Winterbourn, 1990). 
Figure 17 displays the spectra of Hb, oxyHb, and metHb from 450 – 700 nm. 
 





 Glioma is a tumor occurring within the brain and spinal cord stemming from glial 
cells (Glioma, 2019). Glial cells are brain cells which support nerve cells (Glioma, 2019). 
There are three types of glial cells which can form into tumors, and the gliomas are 
classified by the type of glial cell that produced the tumor (Glioma, 2019). By knowing the 
glial cell which caused the glioma, it can help predict how the tumor will act over time and 
what treatments would be the most effective (Glioma, 2019). The three types of glial cells 
which form into gliomas are: astrocytomas, ependymomas, and oligodendrogliomas 
(Glioma, 2019). Astrocytomas gliomas include astrocytoma, anaplastic astrocytoma, and 
glioblastoma (Glioma, 2019). Anaplastic ependymoma, myxopapillary ependymoma, and 
subependymoma are categorized as ependymomas gliomas (Glioma, 2019). Lastly, 
oligodendrogliomas contain oligodendroglioma, anaplastic oligodendroglioma, and 
anaplastic oligoastrocytoma (Glioma, 2019). For the  purpose of this paper, only 
glioblastoma will be expanded upon. For more information about astrocytomas, 
ependymomas, and oligodendrogliomas see references ‘Glioma: Astrocytoma’ (Glioma: 
Astrocytoma, 2019), ‘Brain tumor: Ependymoma’ (Brain tumor: Ependymoma, 2019), and 
‘Glioma: Oligodendroglioma’ (Glioma: Oligodendroglioma, 2019), respectively. 
 Glioblastoma, or glioblastoma multiforme (GBM), is classified by the World 
Health Organization (WHO) as a grade IV glioma. It is the most common and lethal brain 
tumor in adults and accounts for 45% of all malignant brain tumors (GBM agile: A 
revolutionary new adaptive trial platform, 2019). The median survival rate upon diagnosis 
is about one to two years, and 95% die within five years (GBM agile: A revolutionary new 
adaptive trial platform, 2019). Different forms of treatment are surgery, radiation, 
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chemotherapy, tumor treating fields, and targeted drug therapy (Glioma: Glioblastoma, 
2019). However, a cure is not often possible for GBM. Due to consistent poor prognoses 
for patients with this aggressive and persistent brain tumor, the hopes of developing new 
and more effective treatments are being explored.  
 It was stated that cancer stem cells (CSCs) could be the reason that GBM is violent 
and relentless (Lathia, et al., 2015). The ability to self-renew and give rise to a 
differentiated progeny is the definition of a CSC (Lathia, et al., 2015). Their functional 
characteristics are they can generate a tumor when transplanted for a second time into a 
body containing cellular heterogeneity and progeny with fluctuating degrees of self-
renewal capabilities (Lathia, et al., 2015). The term ‘stem cell’ does not imply the cells 
formed from altered stem cells, because there is evidence that multiple cell types are 
susceptible to form cancerous cells (Lathia, et al., 2015). Efforts to identify and isolate 
CSCs have been difficult. Surface markers, like SOX2, CD133, and CD44, have been used 
to identify CSCs, which is then coupled with cytometry to separate them. This method of 
isolation has contributed to the research progress of CSCs (Duan, et al., 2013).  
It is known that CSCs thrive in stressful conditions, such as hypoxia, low glucose, 
inflammation, oxidative stress, and acidic stress (Schonberg, et al., 2015). For all these 
situations, iron metabolism enables the effects and growth of CSCs (Schonberg, et al., 
2015). A direct source of CSC resistance to therapy and tumorigenicity may be uncovered 
by exploiting the abnormal iron regulation within these combinations of conditions within 
tumors (Schonberg, et al., 2015). It was hypothesized that CSCs in GBM search out iron 
within regulatory functions within the body typically for the liver and specific regions of 
the brain, like choroid plexus, for the transferrin consumption and excretion, which 
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increases the intracellular iron concentrations of CSCs (Schonberg, et al., 2015). 
Transferrin (TF) is the primary iron storage protein and iron metabolism within the body 
(Brem, et al., 2006).  
An important observation made by Schonberg, et al., was within an ex vivo 
transplant model and a 3D reconstruction of TF co-localization of a tumor cell surface, 
demonstrated that more than 20-fold higher amount of TF were bound to CSCs than non-
CSCs in the same conditions. Also, an increased level of transferrin receptors (TfRs) was 
detected (Schonberg, et al., 2015). The prime path for iron uptake necessitates ferric iron 
(Fe3+) to bind to TF and attach to TfRs on the cell membrane. Many cancers, such as 
bladder, breast, glioma, leukemia, lung, and lymphoma, express abnormally high quantities 
of TfRs, which in turn suggests that tumor cells display a high demand for iron (Schonberg, 
et al., 2015). From this information, it is apparent that TfR activity plays a part in tumor 
growth (Schonberg, et al., 2015). Iron bound to hemoglobin is one of the most common 
types of iron within the human brain (Brem, et al., 2006). The upregulated iron trafficking 
in GBM CSCs indicate they may possess intrinsic magnetic potential, which means CSCs 
exhibit nearly paramagnetic properties (Brem, et al., 2006). Through CTV, MDM, 
cytosmears, and fluorescent staining, it was investigated if CSCs could be differentiated 
and separated from other types of brain progenitor cells. Further explanation of the 
materials used for these experiments are described in Section 3.5.1.   
2.10 Giddings Velocity Profile  
 When separating out viable RBCs for use in transfusions, scaling up the process 
from small amounts of blood, ~15 mL to 1 L, is always being explored. An idea which was 
considered was to couple magnetic separation with a temperature gradient being applied to 
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the sample suspension. J. Calvin Giddings developed a temperature gradient velocity 
profile, which would facilitate separation between two species by means of natural 
convection. For example, when a pot of water is placed on a stove top to boil, the water at 
the bottom heats up causing the density to drop. It then rises to the top of the pot, while the 
cooler water, with a higher density, moves to the bottom to replace it. Figure 18 represents 
an example of a velocity profile within a thermogravitational column.  
 
Figure 18: Representation of the Giddings velocity profile with a temperature gradient within the fluid (Giddings, 1991). 
 

















Here ρ is the density, γ is the thermal expansion coefficient, g is the gravitational constant 
of 9.81 m/s2, ΔT is the temperature difference between the hot wall and the cold wall, η is 
the viscosity of the fluid, y is the distance from the cold wall, and w is the width of the 
channel. Parameters ρ, γ, and η were evaluated for the fluid at the cold wall. Decreasing 
the viscosity of the fluid, having a larger temperature difference between the hot and cold 
walls, and increasing the channel thickness would increase convective flow to facilitate 










MATERIALS AND METHODS 
3.1 Determination of the Magnetophoretic Driving Force for the Cell Tracking 
Velocimetry Magnet Assembly 
3.1.1 Materials 
Polystyrene (PS) particles of 2.7 µm nominal diameter were synthesized in 
Professor Shlomo Margel’s Laboratory in the Department of Chemistry at Bar-Ilan 
University located in Ramat Gan, Israel in 2000 (Moore L. R., et al., 2000). They were 
originally measured to have a radius of 1.35 ± 0.02 µm, as evaluated by a sub-micron 
particle analyzer (model N4MD, Coulter Electronics Ltd., Luton, UK), and a volumetric 
susceptibility of -8.2110-5 (SI units). These were kept in a powder form and stored at room 
temperature. Their radius was re-evaluated upon reconstitution in buffer solution with a 
Beckman-Coulter Multisizer 4e by Mitchell Weigand in Dr. Jeffrey Chalmers Lab at The 
Ohio State University in Columbus, OH, to have a mean radius of 1.42 ± 0.02 µm. The 
particles were tested in a 0.5 M Magnevist in MDM buffer solution. MDM buffer is a 
mixture of 0.1% weight/volume Pluronic F-68 (Sigma Aldrich), 2 mM EDTA (Sigma 
Aldrich), and 0.02% weight/volume Sodium Azide (NaN3) (Sigma Aldrich) in 100 mL of 
10PBS (Phosphate Buffer Solution) free of calcium and magnesium (Cleveland Clinic 
42 
 
Main Campus Media Core Services). A Vortex Genie-2 (Scientific Industries, Bohemia, 
NY) was operated to mix the particles, MDM buffer, and Magnevist.  
Two three-way Hamilton valves were utilized, intended to be chemically inert, with 
plug type ‘T’, with polytetrafluoroethylene (PTFE) and Kel-F flow path, rated for 100 psig. 
Male chromatography fittings (¼-28  1/16”) were used with poly ether ether ketone 
(PEEK) tubing (1/16” OD  0.02” ID; Upchurch Scientific) to connect to the square 
borosilicate glass channel (1.4 mm OD  1.0 mm ID; VitroCom #8100). Figure 19 is an 
image of the assembly itself. Approximately 2 cm of 1/16” ID silicone tubing was utilized 
to interface the PEEK tubing to the glass channel and wrapped with 28 AWG bare copper 
wire to secure the seal. Phar-Med (LS-16, Saint-Gobain) was placed over the silicone 
tubing and secured with 4” wire ties to minimize oxygen transport to the sample within the 
tubing. Connected to the Hamilton valves were two 5 mL B-D disposable, plastic syringes 
by means of a ¼-28 male-to-female Luer adaptors from Upchurch Scientific. These 




Figure 19: Picture of the CTV system utilized for the Sm verification experiments. 
 
For the CTV setup, a 5 objective lens (LMPlanFl, Olympus, Japan), 3.3 photo 
eyepiece (U-PMTVC, Olympus, Japan), and CCD camera (Retiga 200R, QImaging, 
Canada) were used to capture the images of the particle motion within the magnetic field 
through the Video Savant 4 software (Xue, et al., 2019). This software allows the user to 
select the region of interest (ROI), gain, exposure time, frame rate, number of images in a 
set, and the image file type (*.RAW). The PC utilized was a Dell OptiPlex 980 with an 
Intel Core I7 280 GHz processor, 8.0 GB RAM, and 64-bit Win7 Pro OS. The camera and 
the computer are connected by firewire (IEEE 1394) cable to a firewire card installed in 
the PC.  
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A solution with a well-defined magnetic susceptibility (Δχ) was utilized, made up 
of polystyrene beads, Magnevist®, and magnetic deposition microscopy (MDM) buffer. 
Magnevist is a gadolinium magnetic resonance imaging (MRI) contrast agent made by 
Bayer AG (Magnevist®, 2017), and its systematic name is gadopentetate dimeglumine 
(C28H54GdN5O20), which has a similar volumetric, magnetic susceptibility to gadolinium 
at 7.5810-5 (SI) (Lide, 2005). Due to the paramagnetic susceptibility of the Magnevist, the 
diamagnetic PS particles should move away from the magnet indicating a significant 
diamagnetic component relative to the Magnevist/MDM buffer solution. Equation 2.12 
was used to determine the magnetic susceptibility of the solution, difference between the 
Magnevist and the MDM buffer, which is similar to water at -9.03510-6 (SI). 
3.1.2 Methods  
 To begin, 1 g of PS particles was weighed and added to a 15 mL Falcon tube (Fisher 
Scientific) with 10 mL of MDM buffer. Then 40 µL of the PS particles were pipetted into 
a 15 mL Falcon tube (Fisher Scientific), followed by 5 mL of Magnevist, and 5 mL of 
MDM buffer for a concentration of ~100,000 PS particles/mL. The solution was then 
vortexed on the Genie-2 for 15 – 30 seconds at the highest setting of 10 at room temperature 
to ensure the solution was well-mixed. Next, part of the solution was drawn into a 5 mL 
syringe and it was attached to the Luer adaptors connected to the Hamilton valve on one 
end of the CTV channel. An empty syringe was attached to the Hamilton valve on the 




Figure 20: Schematic of the empty syringe on the left and full syringe on the right attached to the Hamilton valves. 
 
The Hamilton valves were turned to allow for the sample to be pushed through the channel 
to the empty syringe. About 0.2 mL of sample was pushed through the channel over a time 
frame of 3 seconds, the Hamilton valves were closed to stop fluid flow, and it was given 
30 seconds of relaxation time before recording the motion of the particles. Next, the record 
button in the Video Savant software was pressed to begin recording for 60 frames at a 
frame rate of 1 second, totaling a minute of acquisition time. Once the recording was 
completed, the images were reviewed to ensure the particle’s motion were uniform in 
velocity and direction, and they were saved according to the nomenclature specified by the 
CTV logbook as set one. This process was repeated 11 times, over a time span of 25 – 30 
minutes, for a total of 12 sets for the FOV position at a designated distance of 4 mm from 
the edge of the magnet. The additional three positions, 4.5, 5, and 5.5 mm from the edge 
of the magnet, as seen in Figure 21, were tested through the same procedure to verify the 




Figure 21: Edge of the CTV magnet in the center of the FOV within Video Savant.  
 
3.1.3 MSB-Auto Methods to Measure the Magnetic Susceptibility of the MDM Buffer 
and Magnevist Solution 
To ensure the magnetic susceptibility found in literature was accurate for MDM 
buffer and Magnevist, the solutions were verified with the MSB-Auto. Each experiment 
began by measuring an empty MSB Auto tube in order to account for the magnetic 
susceptibility of the tube itself, displayed in Figure 9. Next, the MSB Auto machine was 
turned on and given time to tare to zero before placing the empty tube into the measuring 
slot. Once the empty tube was measured, the range button was pressed to scale the value 
shown on the screen by a multiple of ten, to go from the 10-4 V range to the 10-5 V range. 
The unit V is used to represent the volumetric magnetic susceptibility in CGS units, 
cm3/mol or cm3/g. The range button is pressed again to scale the value to the 10-6 V range, 
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and finally one last time to scale to the 10-7 V range. The value displayed on the screen, 
was the value recorded as the volumetric, magnetic susceptibility. This was repeated four 
times, for a total of five readings for the empty tube. Next, the 50/50 mixture of the MDM 
buffer and Magnevist solution was tested. About 200 µL was pipetted into the empty tube, 
which was just measured, to reach a height of about 1.5 cm from the bottom of the tube. 
Measurements for the solution were obtained the same way as the empty tube, but the range 
button was only pressed twice instead of three times due to an overflow error when it was 
pressed a third time. Just like the empty tube, the solution sample was measured for a total 
of five readings. This procedure was also completed for pure Magnevist, pure MDM buffer, 
0.25 mL of Magnevist in MDM buffer, 0.125 mL of Magnevist in MDM buffer, 0.0625 
mL of Magnevist in MDM buffer, and 0.03125 mL of Magnevist in MDM buffer. 
3.2 Spectrophotometry  
3.2.1 Materials 
 A 5 mL tube of whole blood with a pink top was obtained from the Pathology Lab 
at the Cleveland Clinic Main Campus Hospital. The pink top tube contains dipotassium 
ethylenediaminetetraacetic acid (K2EDTA) to prevent the blood from coagulating until it 
can be tested by the Pathology Lab. The Institutional Review Board (IRB) regulations were 
followed for these samples to protect the rights and welfare of the person whose blood was 
used (Cleveland Clinic IRB #10-1064: EXEMPT. Magnetophoretic Cell Sorting and 
Analysis, P.I.: Maciej Zborowski). This blood was used to make metHb (made with 1PBS 
and sodium nitrite, NaNO2) and oxyHb to be tested within the spectrophotometer. Samples 
were placed in a 1.5 mL acrylic cuvette from VWR International (Radnor, Pennsylvania) 
to be measured in the Beckman Coulter DU® 730 Spectrophotometer (Brea, California). 
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Specifications for the spectrophotometer are in Appendix A, Table XI, while an image of 
the spectrophotometer and cuvette are displayed below. 
 
Figure 22: Spectrophotometer by Beckman Coulter and cuvettes by VWR utilized for the spectrophotometer experiments.  
 
The samples were washed with 1PBS, made from 10PBS and MilliQ water (double 
deionized water, Cleveland Clinic, LRI), in 15 mL Falcon tubes (Fisher Scientific) in the 
Beckman Coulter Allegra™ 6R Centrifuge (Brea, California). The last material utilized for 
these experiments was distilled water obtained from the house line at the Cleveland Clinic, 
LRI building.  
3.2.2 Methods  
 Before samples were made, 1 L of 1PBS was made by mixing 100 mL of 10PBS 
(Cleveland Clinic Media Core) and 900 mL of MilliQ water in a 1 L Pyrex bottle. Next, 
metHb was prepared by mixing 0.0119 g of NaNO2 with 10 mL of 1PBS in a 15 mL 
Falcon tube. This was then mixed with the Vortex Genie-2 at the highest setting to ensure 
the solution was well mixed. After, 50 µL of whole blood was added to the mixture and set 
into an incubator at 37°C for 30 minutes to allow for the RBCs to convert to metHb. While 
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the metHb was forming, 50 µL of whole blood was added to another 15 mL Falcon tube 
with only 10 mL of 1PBS to create oxyHb. Then, the oxyHb sample was washed with 
1PBS three times at 1,500 rpm for 5 minutes to guarantee all the white blood cells, 
platelets, and other residual components from the whole blood were removed from the 
sample. After each wash, the supernatant was removed and discarded in the biological 
waste container. When the metHb sample was done incubating, it was also washed the 
same as the oxyHb sample. Once the samples were ready to be tested, 1 mL of distilled 
water was pipetted into two cuvettes, and then 0.3 mL of the oxyHb was added to one and 
0.3 mL of the metHb was added to the other. One cuvette was measured in the 
spectrophotometer at a time over the range of 500 – 700 nm. The spectrums for each sample 
and concentration calculations completed utilizing Equations 2.32 – 2.34 are displayed and 
discussed in Chapter 4. 
3.3 Modifications made to the Cell Tracking Velocimetry System for the 
Deoxygenation of Red Blood Cells 
 Before experiments of magnetophoresis of RBCs at different deoxygenation levels 
could begin, the CTV system utilized to determine Sm had to be modified. A schematic of 
the original setup is in Figure 23. In order to modify the system, tubing had to be connected 
to allow for gas flow into the deoxygenation vessel and for sample flow from the vessel to 
the syringes for image acquisition. Therefore, Figure 23 was modified to account for these 
needed changes and the schematic of the system is found in Figure 24 and an image of the 
setup is in Figure 25 with a closeup image of the magnet assembly in Figure 26. For more 




Figure 23: Adapted schematic of original CTV setup (Xue, et al., 2019). 
 
 
Figure 24: Modified CTV setup for the deoxygenation of RBC experiments (Xue, et al., 2019). 1) Flow meters utilized to 
regulate the compressed air and compressed N2 to the system. 2) Humidifier to wet the gases. 3) Stir bar placed in the 
deoxygenation vessel and the Fisher Scientific Lab Disc Magnetic Stirrer placed under the vessel to ensure the system is 
well-mixed. 4) Deoxygenation vessel and sample solution inside it. 5) N2 bleed-off tubing. 6) RDO® Rugged Dissolved 
Oxygen (DO) Sensor and Orion Star A213 Dissolved Oxygen Meter. 7) NOx tubing connecting the deoxygenation vessel 
to the syringes for sample measurement. 8) Mk V magnet assembly. 9) PEEK tubing connecting the syringes with the 
sample to the glass channel which runs through the magnet assembly itself to the other syringe. 10) 10 mL glass syringes 





Figure 25: Full CTV setup for deoxygenation experiments. 
 
 
Figure 26: Magnet assembly with glass syringes, and Hamilton valves. 
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Previous experiments analyzing the magnetic mobility of fully deoxygenated RBCs 
completed by Dr. Wei Xue, (Xue, 2016) utilized a different DO probe and meter. For the 
experiments done here, the RDO® Rugged Dissolved Oxygen sensor (Thermo Scientific, 
Waltham, MA) and Orion Star A213 Dissolved Oxygen Meter (Thermo Scientific, 
Waltham, MA) were used. Specifications and dimensions of the probe are in Appendix A, 
Tables XIV and XV, respectively, while specifications for the meter are in Appendix A, 
Table XVI. Figure 27 below displays images of the meter and probe. 
  
Figure 27: Left: Orion Star A213 dissolved oxygen meter from Thermo Scientific. (Component number 7 in Figure 25) 
Right: Orion™ RDO® Rugged Dissolved Oxygen sensor from Thermo Scientific. (Component number 6 in Figure 25) 
 
Along with the new DO probe and meter, a new deoxygenation vessel was designed 
to meet the required minimum immersion depth of the probe to measure the dissolved 
oxygen saturation of the sample solution. This was completed within SolidWorks, 
developed by Dassault Systèmes, in collaboration with Principal Research Engineer, Lee 
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Moore at the Lerner Research Institute at the Cleveland Clinic Main Campus, and 3D-
printed. Rob Geszler operated a PolyJet printer (Stratsys, Eden Prairie, MN) with 
VeroClear resin, which is optically translucent with ABS-like mechanical properties to 3D-
print the vessel. A schematic of the new deoxygenation vessel is shown in Figure 28 with 
the dimensions in Table II. This design allowed for a sample volume of more than 50 mL, 
while maintaining the required 40 mm minimum immersion depth for the probe.  
  
Figure 28: A schematic (left) and image (right) of the 3-D printed deoxygenation vessel (part of component numbers 3, 4, 
5, and 6 in Figure 25). 
 
Table II: Dimensions of the deoxygenation vessel designed in collaboration with Lee Moore. 
Deoxygenation Vessel Dimensions 
Parameter Value Units 
Overall Height 77 mm 
Lower Half Height 40 mm 
Lower Half Inner Diameter 29 mm 
Upper Half Height 14.3 mm 
Upper Half Inner Diameter 91 mm 
Overall Volume 110 cm3 
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3.4 Red Blood Cell Deoxygenation 
3.4.1 Materials 
To begin an experiment a 5 mL tube of whole blood with a pink top was obtained 
from the Pathology Lab at the Cleveland Clinic Main Campus Hospital, as described in 
Section 3.2.1. Again, these samples followed the Institutional Review Board (IRB) 
regulations to protect the rights and welfare of the person’s whose blood was used 
(Cleveland Clinic IRB #10-1064: EXEMPT. Magnetophoretic Cell Sorting and Analysis, 
P.I.: Maciej Zborowski). 
The modified CTV apparatus displayed in Figure 25 shows the components of the 
system labeled with a number for easy identification. The flow meters are labeled by #1. 
The one connected to the compressed nitrogen (N2) tank from Praxair was an Oakton™ 
Gildmont™ Shielded laboratory Direct-Reading Flowmeter (Fisher Scientific, Hampton, 
NM), while the flow meter connected to the compressed air from the Cleveland Clinic 
Main Campus house source, was a Bel-Art™ SP Scienceware™ Riteflow™ Mounted 
Flowmeter (Fisher Scientific, Hampton, NM). An image of these flow meters is in Figure 
29. The specifications for each meter are in Appendix A, Table’s XII and XIII, respectively. 
The humidifier was labeled with #2, which is a 100 mL Pyrex bottle with a lid allowing 
for gas flow in and out, contained 40 mL, or less, of water to aerate the gases to eliminate 
water removal from the cells and the system to avoid the cells dying due to increased 
osmotic pressure. Number 3 denoted the stir bar and plate to ensure the sample solution 
within the vessel was well-mixed. The rest of the components used for these experiments 
were described above in Section 3.3. How the sample solutions were prepared will be 




Figure 29: Flow meters utilized within the deoxygenation system. (Components 1 from Figure 25) 
 
3.4.2 Methods for Calibrating the Dissolved Oxygen Probe and Meter 
 Before experiments could be completed, the DO probe and meter were calibrated 
for 100% saturated with air and 0% saturated with air. Instructions to complete the 
calibration steps were found in the manual for the DO meter (Orion star™ A213 dissolved 
oxygen benchtop meter, 2015). The probe was placed through the hole in the lid of the 
deoxygenation vessel and a stir bar was placed at the bottom of the vessel. NOx tubing 
connected the compressed air flow to the flow meter to the humidifier and into the 90 mL 
of distilled water in the deoxygenation vessel. First, the meter was turned on and the initial 
reading of O2 concentration in mg/L, temperature units of °C, and percent O2 saturation 
were recorded. Next, the stir bar was turned on to about 30 – 40 rpm and the compressed 
air flow was turned on to the 100 mark, corresponding to about 14 mL/min. On the meter 
display, the ‘f1’ key corresponded to calibration. This button was pressed, and four 
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calibration options were given: ‘Air’, ‘Water’, ‘Manual’, and ‘Set Zero’. The ‘Air’ option 
was selected. After, the ‘Start’ selection was pressed and calibration began. When the 
percent saturated value reached 100% and stabilized, which corresponded to 160 mmHg, 
8.05 mg/L at 22.5 °C, calibration was completed and logged in the meter. 
 For these experiments, since the percent saturated readings go below 10% 
saturation, about 17 mmHg, the ‘Set Zero’ calibration was completed. This was completed 
in the same fashion as the 100% calibration was done, but instead of bubbling compressed 
air into the deoxygenation vessel, N2 was utilized. The N2 flow was given about an hour to 
allow for the vessel to be evacuated of air. After about an hour of N2 flow, the ‘f1’ 
calibration button was again pressed. This time the ‘Set Zero’ option was selected, and then 
‘Start’ was pressed. Once the percent saturated point was at 0.1% and stabilized, or 0.01 
mg/L at 24.9 °C, calibration stopped, and the meter logged 0.1%, 1.7 mmHg, as the 0% 
saturation value.  
3.4.3 Methods for Deoxygenation Experiments     
After obtaining a blood sample the morning of an experiment, 1 mL of whole blood 
is removed and pipetted into a 15 mL Falcon tube. This sample was then centrifuged at 
1,500 rpm for 5 minutes at room temperature in the Beckman Coulter Allegra™ 6R 
Centrifuge. While centrifugation was being completed, 90 mL of 1PBS (phosphate buffer 
solution) was added to the deoxygenation vessel. Once centrifugation is completed, the 
Falcon tube is removed and the supernatant, containing platelets, white blood cells, and 
residual K2EDTA, was pipetted into the biological waste. Next, 18 µL of the pelleted RBCs 
were pipetted into the 90 mL of 1PBS in the deoxygenation vessel, which was estimated 
to be 100,000 RBCs/mL based on the 5 billion RBCs/mL concentration of whole blood. A 
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stir bar was placed in the bottom of the vessel and the lid, with the DO probe through the 
center, was screwed on. The vessel was positioned on the magnetic plate to turn the stir 
bar, and it was turned on. Next, the DO meter was turned on to obtain the initial reading 
from the sample solution and it was recorded. The salinity of the solution was set to 8.9% 
within the DO meter to account for the salt content in the 1PBS and RBCs. After the 
initial reading was taken, the compressed air flow was turned on to flood the sample 
solution with air to reach the 100% saturated point of the experiment, 160 mmHg.  
Once the system stabilized at or above 100% saturated, the three-way Hamilton 
valve, labeled A in Figure 30, was turned to allow the sample to flow into the CTV system. 
Valve B was turned to allow the sample to flow through the channel to valve C and be 
drawn into the glass syringe. After flushing the channel with 2 mL of sample, it was 
disposed of in the waste container connected to valve C. Following the same procedure, 
another milliliter was flushed through the system and disposed of. Next, 2 mL of solution 
was drawn into the system for data acquisition, and valve A was turned to no longer allow 
sample from the vessel to flow into the CTV system. The sample was then drawn and 




Figure 30: Deoxygenation system set up labeling the three three-way Hamilton valves. 
 
To obtain a sample set, about 0.2 mL of sample was pushed into the channel and 
given two minutes of relaxation time. Once the two minutes were over, the record button 
in the Video Savant software was pressed to begin recording the frame-by-frame motion 
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of the cells within the channel at a frame rate of two seconds until 60 frames was reached, 
for a total of two minutes of recording time. The images were reviewed to ensure that cell 
motion was uniform in velocity and direction, and then they were saved according to the 
nomenclature specified by the CTV Logbook as set one. This procedure was repeated seven 
times for this 2 mL sample at 100% oxygenated at room temperature, which took ~30 – 35 
minutes to complete. After eight sets were completed, the protocol was repeated for the 
nine remaining oxygenation levels. The specified oxygenation levels tested for a single 
experiment are in Table III. Experiment #1 took about 9 hours to complete. This was the 
average amount of time it took for each experiment, not including retrieving the blood 
sample and preparation. Experiments 1 – 5 were completed in this fashion by starting at 
100% oxygenated and decreasing to as close to 0% oxygenated as possible, typically 0.1%, 
1.7 mmHg or 0.01 mg/L. 
Table III: Theoretical oxygenation levels for one experiment to determine if CTV is capable to detect differences in the 
magnetic mobility of RBCs. 
Theoretical Oxygenation Levels for one Experiment at Room Temperature 
Partial Pressure of O2, 
mmHg 






160 8.35 100 23 
60 3.14 37.5 76 
40 2.09 25 50 
30 1.57 18.75 50 
25 1.31 15.63 48 
20 1.05 12.5 78 
15 0.79 9.38 49 
10 0.53 6.25 58 
5 0.26 3.13 61 




3.4.4 Methods of Analysis  
Recorded images saved through the Video Savant software were renamed to be 
analyzed through ImageView, a custom image analyzing software for internal use only, 
created at The Ohio State University in Dr. Jeffrey Chalmers’ Lab in the Chemical 
Engineering Department. The first image from the first set being analyzed was selected, 
then the processing button is pressed. Figure 31 displays the CTV parameters within the 
imaging software which were adjusted to track the particle frame-by-frame. After the 
position was traced, the distance the particle traveled was calculated from an average 
velocity over five frames divided by the frame rate specified in the Video Savant software 
(one second for the Sm verification and the glioma experiments and two seconds for the 
RBC deoxygenation experiments). Therefore, on average a single cell susceptibility 




Figure 31: Parameters changed in ImageView to ensure particles are tracked accurately. Under the ‘Set, Frame, & Timing 
Information’ Section 1) ‘Setting End’ is set to the corresponding number of sets being analyzed 2) ‘Settling End’ indicates 
the amount of images taken, or frames, per set 3) ‘Settling Interval (ms)’ is changed to the frame rate specified in Video 
Savant in milliseconds. In the ‘Particle Identification’ Section 4) ‘Min’ indicates the minimum number of pixels a particle 
will occupy at a given time 5) ‘Threshold’ brightens the images when it is reduced and dims the images when it is 
increased. Section ‘Minimum Tracking Frame Numbers’ 6) ‘Settling’ represents the consecutive number of frames a 
particle must be tracked to be counted in the average. ‘Image Information’ 7) ‘Width’ and ‘Height’ are also specified in 
Video Savant before the images are recorded. In the ‘Calibration Information’ Section 8) the number of pixels in 10 mm 
wide and 10 mm tall are specified, and for the 5 objective lens 6,519 pixels correspond to 10 mm. Lastly, the ‘Operation’ 
Section 9) all the boxes are checked besides the ‘Batch Proc’ box. 
 
Within ImageView, all repeats in a set were analyzed at once, which created a .txt 
file with all the information from the analysis. From there, the file is opened in Excel as a 
delimited file and run through two Macros developed by two visiting students from The 
Ohio State University by the names of Aaron Richardson and Masa Nakamura (Nakamura, 
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et al., 2001). Over the years, the Macros have been modified to what they are today by Mr. 
Lee Moore, Dr. P. Stephen Williams, and Dr. Seungjoo Haam between 2005 – 2012. The 
first Macro, ‘sorter2’, organized the information into a recognizable format to be run 
through the second Macro, ‘Step1’. Upon completion of running the Macros, the mean, 
median, mode, standard deviation, variance, 95% confidence limits, and coefficient of 
variance for the magnetic mobility and the sedimentation velocity are provided. Also, three 
graphs for both the magnetic mobility and the sedimentation velocity are created with wide 
binning, middle binning, and narrow binning. The raw magnetic and sedimentation 
velocities are located on the second sheet labeled ‘DATA-1’ in columns B and C in the 
Excel file, where the magnetic velocity is labeled ‘u_avg’ and the sedimentation velocity 
is ‘v_avg’. The final version of the Excel file is then saved into the CTV results file on the 
computer. This method of analysis was completed for the Sm verification study, the 
deoxygenation of RBC experiments, and the glioma experiments. 
3.4.5 Analysis of Sm Verification Experiments 
 Utilizing Equations 2.10 through 2.20 in Sections 2.6.1, an Excel file was created 
to calculate Sm for the four positions identified in Section 3.1.2.  
3.4.6 Analysis of RBC Deoxygenation Experiments 
A MATLAB code generated by Robert Royer and modified by Dr. Maciej 
Zborowski and me in 2018-2019, was then utilized to obtain more information from the 
Excel files and representative graphs for the RBC deoxygenation experiments. The 
MATLAB code is in Appendix B in its entirety. To begin, the ‘Run’ button in the 
MATLAB ‘Live Editor’ section was pressed, and the file explorer window popped up. 
Here the Excel file to be analyzed was selected, and the magnetic and sedimentation 
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velocities from page ‘DATA-1’ in the Excel file were extracted. First, the data was utilized 
to create a scatter plot of the sedimentation velocity versus the magnetic velocity including 
marginal histograms of the count of particles at specific locations. The points graphed on 
the scatter plots were completed utilizing a color-coding system, indicating where the most 
particles fell on the plot and the color bar with the high volume (yellow) and low volume 
(blue) color scheme located to the right of the sedimentation velocity histogram. Next, k-
mean clustering was utilized to partition the sample group into two different clusters with 
similar data points and discover underlying patterns within the dataset (Garbade, 2018). 
Once the clusters were identified, they were plotted on the sedimentation versus 
magnetic velocity scatter plot with cluster 1, identified by red points and cluster 2, 
identified by blue points, and their center of masses were labeled by black dots in the 
groups. Each group was graphed separately in the same manner as the whole dataset was 
first graphed in the color-coded scatter plot with histograms. The magnetic histograms were 
then fitted to a gaussian model to determine the peak (a1), the mode (b1), and the standard 
deviation (c1) for each cluster. The gaussian fit equation utilized is found in Equation 3.1 
below. The last graph generated in the MATLAB code was a combination of the original 
magnetic histogram from the whole dataset in a blue stair-type graph with a black line 
corresponding to the sum of cluster 1 and 2’s gaussian curves, the light purple line graphing 
subset 1’s gaussian, and the red line plotting subset 2’s gaussian. To compare the 
functionality of the gaussian curve fitting code in MATLAB, a Welch’s t-test for unequal 
variances and unequal sample sizes was coded. This statistical analysis is an adaptation of 
the Student’s t-test; however, it is more reliable for samples with unequal variances and/or 












The last part of the MATLAB code compiles key points from data analysis into an 
Excel file. Original magnetic and sedimentation velocities were put into the sheet labeled 
‘All’. Points within cluster 2 were put into a sheet labeled ‘A’ for subset A, while points in 
cluster 1 were located in the sheet labeled ‘B’. The center of masses for each cluster and 
their standard deviation were in sheet ‘CENTS’. Gaussian coefficients for subset A were 
put in sheet ‘GaussA’ and subset B were put in sheet ‘GaussB’. Welch’s t-test results were 
stored in sheet ‘Ttest’ with a p-value equal to 0.95. This included the alpha-value, the 
number of points, mean, and standard deviation of each cluster, along with the degrees of 
freedom denoted as v, the t statistic as tval, and the 1-tail t-distribution denoted as ‘tail1’ 
and the 2-tail t-distribution denoted as ‘tail2’. Equation’s 3.2 and 3.5 demonstrate how the 
degrees of freedom and the t statistic were calculated for the Welch’s t-test, respectively. 
The sample variance is denoted as s, sample size is N, and ?̅? is the sample mean. The last 
sheet in the Excel file generated from the MATLAB code provides the upper and lower 























𝑣1 = 𝑁1 − 1 (3.3) 
 

















Reduction of the data gathered from the MATLAB code was the last step when 
analyzing the results. The gaussian coefficients of subset A and B at each oxygenation level 
for one experiment were compared, where gaussian 1 was defined as the magnetic velocity 
closest to zero and gaussian 2 was the one farthest from zero. This varies between cluster 
1 and 2 for each oxygenation level. The b-values, or the mode of the gaussian, were then 
plotted versus the oxygenation level they were measured at, with error bars corresponding 
to the c-values, standard deviation of the mode. Next, the b-values were normalized from 
0 to 1 and graphed versus the oxygenation state with a best fit line consistent with the Hill 
equation describing the cooperative binding scheme of oxygen to hemoglobin. In Equation 





From the stated hypothesis, Y follows the Hill equation specified in Equation 3.7 of the 







Equation 3.7 is algebraically manipulated to convert it to have a linear relationship between 
some closed-form functions of Y and x in Equations 3.8 through 3.10. 













Equation 3.8 can be further simplified to Equation 3.9 by introducing variable Z and 






𝑘 ≡ − log(𝑘′) (3.12) 
The desired result, presented in Equation 3.13, is the linear relationship between the 
function of the experimentally measured b-value, log(Z), and the function of the 
independently varied experimental value of pO2, log(x). 
log(𝑍) = nlog(𝑥) + 𝑘 (3.13) 
For these equations, Y is the fractional saturation of oxygen bound to the hemoglobin, n is 
the Hill coefficient also known as the slope of the regression line of the linearized Hill 
equation, which corresponds to Z in Equation 3.11, and k is 10 raised to the negative value 
of the y-intercept from the regression line of the linearized Hill equation. For Equation 3.6, 
y0 is the maximum b-value in an experiment (one experiment corresponds to sets at 160 
mmHg to 0 mmHg) minus the minimum b-value and y is the original b-value minus the 
minimum b-value (Weiss, 1997). The Hill parameters n and k were determined by the usual 
method of least-square fitting of a straight line to the experimental data of log(Z) on log(x), 
whose significance was calculated by the linear regression analysis. For normal blood, 
parameter n ranges from 1.5 – 2.5 for pO2<30 mmHg and reaches the saturation value of 
2.7 at about 30 mmHg (Dash, et al., 2016). From here, conclusions were drawn to 
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determine if the hypothesis was correct about CTV being able to differentiate RBC 
subfractions differing in oxygenation levels. 
3.5 Glioma Progenitor Cell Experiments 
3.5.1 Materials 
 The glioma cell cultures were provided by Soumya Turaga, a graduate student in 
Dr. Justin Lathia’s lab at the Cleveland Clinic, LRI. Originally, three different cultures 
were tested, 3T3 (control), GL26, and GL261, which were all murine models which were 
cultured for more than 20 passages. The 3T3 control were simply neural stem cells, while 
GL26 and GL261 were forms of glioblastoma/ependymoblastoma (Oh, et al., 2014). 
Preclinical testing of immunotherapeutic approaches for GBM have been most extensively 
completed on the GL261 model (Oh, et al., 2014). The GL261 and GL26 models are 
similar, but the GL26 tumors present greater necrosis and vascularity as well as being 
hemorrhagic (Oh, et al., 2014). All these cells were cultured in RPMI (Roswell Park 
Memorial Institute) 1640 media (ThermoFisher Scientific, Waltham, MA) supplemented 
with 10% fetal bovine serum and 1% penicillin/streptomycin, which was also provided by 
Soumya. The last material supplied by Soumya in Dr. Lathia’s lab was 4% PFA 
(paraformaldehyde, made by Soumya Turaga at Cleveland Clinic, LRI) fixative to secure 
the cells onto the Mylar slide after MDM was completed, as well as after a cytosmear was 
generated within the cytospin.  
 The MSB-Auto described in Section 2.3 and the CTV components defined in 
Section 3.1.1 were applied to the glioma experiments to validate the MATLAB analysis. 
Shandon Cytospin 3 (Thermo Fisher Scientific, San Francisco, California), displayed in 
Figure 32, was used to create cytosmears of the glioma cells. Specifications for the 
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instrument are in Appendix A, Table XVII (Cytospin: Cell Preparation System Operator 
Guide, 1997). Components needed for the cytospin were the stainless steel Cytoclip™ slide 
clip, a microscope slide with a circle where the sample is released onto the slide, and a 
disposable Cytofunnel® with a sample chamber and filter card (Cytospin: Cell Preparation 
System Operator Guide, 1997). The method of how the sample was prepared and put 
together with the Cytoclip™, microscope slide, and Cytofunnel® will be described in 
Section 3.5.2. 
 
Figure 32: Shandon Cytospin 3 (Thermo Fisher Scientific, San Francisco, CA) used to create cytosmears of glioma 
cultures (Cytospin: Cell Preparation System Operator Guide, 1997). 
 
The MDM magnet described in Section 2.6.2 was also used to determine if 
magnetic separation is possible between CSCs and other brain cells. The magnet assembly 
was made up of three sizes of neodymium-iron-boron 42 MG Oe energy blocks (Applied 
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Magnet, Plano, TX). The steel yokes and aluminum supports were put together at the 
Cleveland Clinic, LRI. The two interpolar gaps had a width of 1.6 mm each and the 
maximum magnetic field intensity between these gaps in the 0y direction was measured to 
be By = 0.475 T. Five flow channels, each 6.3 mm wide and 15 mm long, were cutout into 
a 0.25 mm thick rubber spacer. The rubber spacer was squeezed between a 0.13 mm thick, 
poly-l-lysine coated Mylar sheet, acting as a microscopy substrate slide, and a 
polycarbonate manifold. The orientation and components in the assembly are displayed in 
Figure 33.  
 
Figure 33: Magnet assembly (Buck, et al., 2014). 
 
To facilitate sample flow through the channel, FEP, 0.508 mm inner diameter  
1.59 mm outer diameter tubing (Zeus Industrial Products, Orangeburg, SC) was threaded 
through the manifold on both the top and bottom. While syringes were connected to the 
tubing leaving the top of the manifold, they were attached to the kd Scientific Legato 210P 
multi-syringe pump, displayed in Figure 34 and specifications in Appendix A, Table XVIII. 
Within the pump, flow rates could be specified and programed, allowing for controlled and 
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precise fluid flow in the channels. The flow rates utilized for the glioma experiments will 
be described in Section 3.5.2. 
 
Figure 34: Legato 210P multi-syringe pump adaptor from kd Scientific (Hollison, MA) utilized in MDM (Legato 
210/210P Syringe Pump, 2016). 
 
3.5.2 Methods  
 First, the RPMI media utilized to culture the cells was tested with the MSB-Auto, 
applying the same procedure described in Section 3.1.3, to ensure the media did not present 
any magnetic properties which could be absorbed by the cells and inadvertently make them 
magnetic. Also, distilled water and MilliQ water were both measured to verify the magnetic 
susceptibility of the RPMI media was not statistically significantly different from water. 
The statistical analysis is in Section 4.4. 
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 The morning of an experiment, a sample was received from Soumya containing 
about 1,000,000 cells/mL of solution. About 10,000 cells were needed for a cytosmear, 
100,000 cells for each of the five MDM channels, 50,000 cells for Countess, and 1,000,000 
cells/mL for CTV. The 50,000 cells for Countess were removed first to give to the 
Cleveland Clinic LRI FlowCore to determine the size and viability of the cells. From 
experiment to experiment, the amount of sample removed from the original 1,000,000 
cells/mL solution for each test varied due to the number of cells Soumya was able to 
provide. Next, five 1.5 mL sample vials were prepared for MDM. The 20,000 cells for two 
cytosmears were then pipetted into a 1.5 mL sample vial, which also contained excess 
RPMI media. The remaining of the cells were utilized for CTV.  
 MDM was the test which took the most amount of time to complete. Therefore, this 
was the first to start running. To begin, the Mylar slide was cut to size to cover the five 
channels, and the bottom right corner was cut diagonally, as seen in Figure 35, to know 
which channel was located where on the slide. Next, ten pieces of tubing was cut about 10 
inches long. The tubing was then pulled at one end with plyers to thin it out to be able to 
thread it into the manifold. Once all ten pieces of tubing were in the manifold, the excess 
tubing on the inside of the manifold was cut off to provide a smooth surface for the rubber 
spacer and Mylar slide to sit. After the rubber spacer and Mylar slides were in place on the 
manifold, all three pieces were sandwiched together with the magnet assembly. The order 
was the magnet assembly, Mylar slide, rubber spacer, then the manifold threaded on four 
bolts sticking out of the outer edges of the magnet assembly. Next, the platen was placed 
next to the manifold on the bolts and screws were tightened to create an airtight seal within 




Figure 35: Schematic of a Mylar slide, 25 mm  75 mm, used within MDM as a microscope slide, cut on the bottom right 
corner to determine the locations of the channels. 
 
When the magnet was assembled, the tubing at the top of the manifold needed to 
be connected to the syringes using a male chromatography fittings (¼-28  1/16”) and ¼-
28 male-to-female Luer adaptors from Upchurch Scientific. The adaptors were a 
modification from the original Hamilton valves utilized for the process, due to 
complications of not every channel drawing up sample when the pump was turned on. Once 
the syringes were connected to the tubing, they were secured to the pump. About 1 mL of 
MDM carrier solution was placed in a 1.5 mL sample vial and placed at the bottom of each 
channel with the tubing placed inside the solution. On the pump, program Nina_C was 
selected to first determine which channels were withdrawing and infusing sample properly, 
and to coat the inside surfaces of the tubing and Mylar slide. The different pump programs 
utilized for the glioma experiments are listed in Table IV. About 10 minutes later, the 
carrier solution was withdrawn into the syringe and infused back into the sample vial, and 
the vials were switched out for the glioma samples. Program Nina_U was selected. 
Table IV: Pump programs implemented by Nina Smith. 
MDM Pump Programs 
Program Name Withdraw/Infuse Rate, mL/min Volume, mL Time, min 
Nina_C 
Withdraw 0.2 0.8 4.0 
Infuse 0.2 0.7 3.5 
Nina_U Withdraw 0.026 0.7 26.92 
Nina_D Infuse 0.03 0.6 20.0 
Nina_M_U Withdraw 0.13 0.6 4.62 
Nina_M_D Infuse 0.13 0.6 4.62 
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 While waiting for MDM to finish, two cytosmears were created, one for PFA, the 
fluorescent fixative, and one for HEMA fixative. First, the 20,000 cells were split into two 
1.5 mL sample vials with RPMI media. After the samples were prepared, the Cytoclip™, 
microscope slide, and the disposable Cytofunnel® were put together as displayed in Figure 
36. Two of these combinations were prepared, with the microscope slide indicating which 
sample would be fixed with HEMA solution and which would be fixed with PFA. Next, 
0.3 mL of the sample solutions were pipetted into the disposable Cytofunnel®. Both 
Cytoclip’s™ were taken over to the Cytospin 3 and placed on opposite sides of the 
centrifuge to keep the system at equilibrium. The machine was then turned on and program 
number 2 was selected, which was preprogramed.  
 
Figure 36: Schematic of how the Cytoclip™ slide clip, the microscope slide, and the disposable Cytofunnel® are put 
together to be placed into the cytospin (Cytospin: Cell Preparation System Operator Guide, 1997).  
 
After 5 minutes, the cytospin stopped and the samples were removed. The 
disposable Cytofunnel® was removed and thrown away in the biological waste bin, while 
the Cytoclip’s™ were placed back into the Cytospin 3, and the machine turned off. The 
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slide marked HEMA fixative was first dunked into the light blue HEMA solution five 
times, then five times in the red HEMA solution, and lastly five times in the purple HEMA 
solution. The slide was then left in the open to dry. Next, about 50 µL of PFA was dropped 
on the cells within the circle on the slide marked PFA. The PFA was left on the cells for 
15 minutes, and then it was washed off by dunking the slide in 1PBS five times. The slide 
was then placed inside the refrigerator at 4°C until Soumya was able to fluorescently stain 
the cells. Once the HEMA slide was dry, a cover slide was placed over top of the slide to 
be taken to ImageCore to be imaged. 
After the cytosmears were finished and while the MDM experiment was still 
running, the sample for CTV was prepared. The CTV procedure described for the Sm 
verification experiments was mimicked. A sample concentration of about ~100,000 
cells/mL was drawn up into a 5 mL syringe. The syringe was attached to the Luer adaptors 
connected to the Hamilton valve on one end of the CTV channel, while an empty syringe 
was attached to the Hamilton valve on the opposite side of the channel. Then the valves 
were turned to allow for about 0.2 mL of the sample to be pushed through the channel to 
the empty syringe over a time span of about 3 seconds. Next, the valves were closed to stop 
fluid flow, and the cells were given about 30 seconds of relaxation time before the motion 
of the cells was recorded. After, the record button in the Video Savant software was pressed 
to begin recording for 60 frames at a frame rate of 1 second, totaling a minute of acquisition 
time. The images were reviewed once the recording was complete to ensure the cells moved 
in a uniform velocity and direction. The images were saved according to the nomenclature 
specified by the CTV logbook as set one. This process was repeated 7 times, for a total of 
8 sets over a time span of 20 – 25 minutes. The methods of analysis for the glioma 
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experiments imitated those for the deoxygenation experiment described in Section 3.4.4 
and 3.4.6. The part not completed, was for the analysis of the gaussians with the Welch t-
test through the data reduction with the Hill equation. 
 Once the MDM program Nina_U was completed, program Nina_D was run. After 
it was done, the sample vials at the bottom of the tubing was switched out for vials 
containing 1 mL of PFA. PFA was drawn into the syringes at the top utilizing program 
Nina_M_U, and the PFA was left sitting in the channels for 15 minutes to allow for the 
cells to be fixed to the Mylar slide. When the 15 minutes was up, program Nina_M_D was 
run, so all the PFA was removed from the tubing and channels back into the sample vials. 
Once this was completed, the system was carefully disassembled. The syringes were 
removed from the pump holding location and the tubing connected to the top of the 
manifold was detached. The tubing at the bottom of the manifold was then disconnected 
and taken out of the sample vial. The sample vial was then closed to ensure none of the 
sample would spill. The tubing, syringes, and the samples were then discarded in the 
biological waste. Next, the magnet assembly was taken apart first by removing the screws 
and the platen. The Mylar slide was peeled off the rubber spacer and placed off to the side 
to confirm it was not contaminated. All the adaptors, rubber spacer, and the manifold were 
cleaned using 70% alcohol and bleach. Lastly, the Mylar slide was taped to a glass slide 
and stored in the refrigerator at 4°C until Soumya was able to stain the cells. 
3.6 Exploration of the Effects of a Temperature Gradient on the Separation of Red 
Blood Cells 
 To begin, theoretical calculations were completed for water at 0°C as the cold wall 
and 40°C for the hot wall, to determine if applying a temperature gradient to the MDM 
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system would facilitate separation of the viable RBCs. The local water velocity profile in 
a thin channel bounded by a ‘cold wall’ (0°C) and a ‘hot wall’ (40°C), due to temperature-
related changes in the local water density and in the absence of imposed volumetric flow, 
were calculated from Equation 2.35 (Giddings, 1991). The numerical values of water 
density, ρ, the water thermal expansion coefficient, γ, the width of the channel, w, the 
temperatures of the ‘hot wall’ and ‘cold wall’, °C, and the water viscosity, η, are listed in 
Table V. The local water velocity, v(y), was calculated as a function of y, which was the 
distance from the ‘cold wall’. The maximum value of the local water velocity induced by 
the temperature difference between the ‘hot’ and ‘cold’ walls was compared to the known 
RBC sedimentation velocity in order to determine if it was large enough to affect the RBC 
sedimentation by entrainment in the falling or rising layer of water in the channel. The 
results are presented as a plot of v(y) on y in Section 4.5. 
Table V: Constants utilized to create Figure 74 Giddings velocity profile.  
Giddings Velocity Profile Parameters 
Parameter Value Units 
Width of Channel 0.25 mm 
Density 998 kg/m3 
Thermal Expansion Coefficient  2.0710-4 1/K 
Dynamic Viscosity 1.0010-3 Pas (Ns/m2) 
Cold Wall Temperature 0 °C 
Hot Wall Temperature 40 °C 
 
Once calculations were completed, computational modeling was begun through a 
cross-platform finite element analysis solver and multiphysics simulation software called 
COMSOL Multiphysics 5.3. Before modeling could be completed with the MDM 
assembly, tutorials for different types of fluid flow were completed. One example was 
erosion within a pipe elbow due to particle contamination. It demonstrated how to setup 
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the single-phase turbulent fluid flow physics within COMSOL, which were needed to 
complete the simulations. From there, the geometry of the pipe was drawn, which is similar 
to how geometries are drawn in SolidWorks. Next, the physics were defined further for the 
model, which was where the turbulent flow entering and exiting the pipe and the inlet 
velocity of the fluid were specified. Then the fluid material was defined as water, and the 
pipe mesh was applied, which distributes the stresses of the flow through the pipe for a 
more realistic representation of the fluid flow. After, a study was computed to determine 
the fluid velocity streamlines and the points within the pipe which experience the most 
pressure. Due to the limitations of the version of COMSOL accessible, the contamination 
particles were not able to be added to the simulation to finish the tutorial.   
Once the tutorial was completed, modeling for the temperature gradient began 
utilizing the same physics from the pipe tutorial, single-phase turbulent fluid flow. First, 
the MDM magnet assembly, originally designed in SolidWorks and provided by Lee R. 
Moore, was imported into the COMSOL software utilizing an .STL file, allowing for a 
more accurate theoretical model. Initially, meshing was attempted with the whole magnet 
assembly, but this caused the program to take a few hours to complete. Therefore, the 
geometry was cut from the whole assembly to just one channel within the assembly.  Figure 
37 displays the whole assembly and just one channel of the assembly. Next, the fluid was 
specified as water and the inlet and outlets were specified. Last, the velocity and pressure 
profiles were generated for water flowing through the single channel.  
Multiple attempts were completed to ensure the fluid was flowing through the 
tubing of the manifold into the channels. The second attempt was done by extruding an 
inlet and outlet from the tubing, which is present in the single channel assembly of Figure 
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37. Attempt number three, tubing was drawn through the manifold holes to the channel 
itself. The last attempt, the tubing walls were selected as boundaries to facilitate fluid flow. 
These simulation results will be further discussed in Chapter IV – Results and Discussion. 
 
 











RESULTS AND DISCUSSION 
4.1 Sm Verification Results 
 The objective of this experiment was to validate the Sm value of the Mk V magnet 
assembly to ensure the particles are exposed to a uniform magnetic field when carrying out 
experiments on CTV. To begin calculations, Equation 2.20 in Section 2.6.1 was utilized to 
convert the mean magnetophoretic mobility (mm3/T-A-s) to the mean magnetic velocity 
(mm/s), utilizing the current Sm value of 365 T-A/mm
2 (Xue, et al., 2019). Next, Δχ of the 
solution was calculated from Equation 2.12, with the assumption that MDM buffer has the 
same magnetic susceptibility as water, and the solution was measured by the MSB-Auto, 
described in Section 3.1.3. The theoretical volumetric, magnetic susceptibility of water is 
-7.1910-7 (CGS), which corresponds to -9.03510-6 (SI) (Zborowski, et al., 2003). The 
50/50 Magnevist and MDM buffer solution was measured to have a magnetic susceptibility 
of 6.7710-5, in SI units, but it was calculated to be 7.5810-5 (SI), which is a 10.68% 
difference between the two values. Then, these values were used to evaluate Equation 2.15 
to obtain an Sm value, where the particle diameter and viscosity of the solution were kept 





Figure 38: Results to determine the FOV location and the value of Sm. 
 
 In Figure 38, the highest Sm value is located at 4.5 mm away from the edge of the 
magnet. Figure 11, of the theoretical model for the Mk V magnet, also indicates around 4.5 
mm away from the edge of the magnet, the Sm value is the highest. However, the 
experimental values for Sm are much higher than the original 365 T-A/mm
2 (theoretical) 
795 ± 212 T-A/mm2 (Δχ from literature) and 880 ± 235 T-A/mm2 (Δχ measured by MSB-
Auto). The potential sources of irregularity are discussed in Section 4.6. 
4.2 Spectrophotometry Results 
 Specific aim number two was to determine the concentration levels of metHb and 
oxyHb within samples through spectrophotometry. As described in Section 3.2.2, the 
spectrum of two samples were measured over a wavelength range of 500 – 700 nm. The 
results are displayed in Figure 39 below. Around wavelength 577 nm, oxyHb rises steeply 


























around 560 nm, both the oxyHb and metHb curves dip into a trough, indicating the presence 
of hemicrhomes, or unstable hemoglobin, within the samples. 
 
Figure 39: Results from running spectrophotometry on the oxyHb and metHb samples over a range of 500 - 700 nm. 
 
Following the experiments, post-processing calculations were completed to determine the 
concentration of oxyHb, metHb, and hemicrhomes in the samples utilizing Equations 2.32 
through 2.34. The results are displayed in Table VI and will be discussed in Section 4.7. 
Due to the high error associated with pipetting small amounts of the sample’s multiple 
times and the accuracy of the spectrophotometer absorbance readings, the values of the 
oxyHb concentration in the metHb sample and hemichrome concentration in the oxyHb 
sample are below zero, however they are within the standard deviation. The suitable 
concentration for oxyHb and metHb for spectrophotometry measurements are 40 µM per 

























Table VI: Concentrations calculated from Equations 2.32-2.34 to obtain the concentration of oxyHb, metHb, and 
hemichrome within the samples analyzed by spectrophotometry.  
Concentration Results Calculated with Winterbourn's Equations 
Type A560 A577 A630 [oxyHb], µM [metHb], µM [hemi], µM 
metHb 0.51 0.52 0.43 -0.36 ± 0.45 119.13 ± 0.45 0.422 ± 0.45 
oxyHb 0.99 1.67 0.08 107.70 ± 1.03 16.42 ± 1.03 -1.0 ± 1.03 
 
4.3 Deoxygenation of Red Blood Cell Results  
 The purpose of the deoxygenation of RBC experiments was to determine if CTV is 
capable of distinguishing different RBC subfractions when the levels of oxygenation were 
varied. Analysis began by running the Excel Macros described in Section 3.4.4 to obtain 
the magnetic mobility and sedimentation velocity results using CTV. The magnetic 
mobility versus the pO2 for Experiments 1 and 2 are shown in Figures 40 and 41, 
respectively. These graphs demonstrate that as the pO2 level decreases, the magnetic 
mobility of the RBCs increases.  
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Figure 41: Magnetic mobility versus the pO2 level for Experiment #2. 
 
These results were then run through the MATLAB code, which generated a variety of 
graphs. Also, the original magnetic mobility and sedimentation velocity data, the original 
data split into cluster’s 1 and 2, the Gaussian coefficients for the separate clusters, and 
Welch’s t-test information was printed to a different Excel file to be further analyzed 
against the Hill equation. 
4.3.1 Results Generated through the MATLAB Code for Experiment #1 
 The MATLAB code generated nine plots when analyzing the data for one 
oxygenation level. For the purpose of this study, only three were analyzed: 1 – the overall 
color coded dataset with the magnetic and sedimentation velocity histograms, the left graph 
in Figure 42, 2 – the original data split into two clusters based on the k-means clustering 
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light purple curves) overlaid on the original magnetic velocity histogram (light blue stairs-
type), and the sum of the cluster Gaussians (black), the top graph in Figure 43. As 
mentioned before, the red curve in the top graph in Figure 43 corresponds to cluster 2, and 
the light purple curve correlates to cluster 1. These three figures are the results of the pO2 
level at 160 mmHg for Experiment #1. The bottom graph in Figure 43, was created by Dr. 
Maciej Zborowski through Maple, is the theoretical behavior of an RBC when it is fully 
oxygenated.  
 
Figure 42: MATLAB graphs generated for the 160-mmHg oxygenation level in Experiment #1. On the left is the whole 









Figure 43: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 160 mmHg. Below: Graph created in 




When comparing the taller gaussian peak to the left (red curve) in the top graph of 
Figure 43 and the gaussian peak in the bottom graph in Figure 43, they are both slightly to 
the left of zero. As the oxygenation level decreased during Experiment #1, the RBC’s 
magnetic velocity increases, as demonstrated in Figures 42 – 61. Again, at each 
oxygenation level, the experimental motion of an RBC (graphs from MATLAB) were 
compared to the theoretical motion predicted from Adair’s Equation 2.25 (graphs created 
in Maple). 
  
Figure 44: MATLAB graphs generated for the 60-mmHg oxygenation level in Experiment #1. On the left is the whole 





Figure 45: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 60 mmHg. Below: Graph created in 






Figure 46: MATLAB graphs generated for the 40-mmHg oxygenation level in Experiment #1. On the top is the whole 






Figure 47: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 40 mmHg. Below: Graph created in 






Figure 48: MATLAB graphs generated for the 30-mmHg oxygenation level in Experiment #1. On the top is the whole 






Figure 49: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 30 mmHg. Below: Graph created in 






Figure 50: MATLAB graphs generated for the 25-mmHg oxygenation level in Experiment #1. On the top is the whole 






Figure 51: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 25 mmHg. Below: Graph created in 






Figure 52: MATLAB graphs generated for the 20-mmHg oxygenation level in Experiment #1. On the top is the whole 






Figure 53: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 20 mmHg. Below: Graph created in 






Figure 54: MATLAB graphs generated for the 15-mmHg oxygenation level in Experiment #1. On the top is the whole 






Figure 55: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 15 mmHg. Below: Graph created in 






Figure 56: MATLAB graphs generated for the 10-mmHg oxygenation level in Experiment #1. On the top is the whole 






Figure 57: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 10 mmHg. Below: Graph created in 






Figure 58: MATLAB graphs generated for the 5-mmHg oxygenation level in Experiment #1. On the top is the whole 






Figure 59: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 5 mmHg. Below: Graph created in Maple 






Figure 60: MATLAB graphs generated for 0.1% O2 saturation level in Experiment #1. On the top is the whole dataset 






Figure 61: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 0.1% O2 saturation level. Below: Graph 




Comparing the top graphs in Figure 43 (160 mmHg) and Figure 61 (about 1.7 
mmHg, or 0.1% saturation) confirms that at lower oxygenation levels (high spin 
hemoglobin molecules, unpaired electrons) the magnetic velocity of an RBC is greater than 
at higher oxygenation levels (low spin hemoglobin molecules, covalently bonded to O2). 
When relating the experimental graphs to the theoretical graphs for 60-30 mmHg, the peaks 
of the gaussians move comparably well with each other. However, for 25 mmHg and lower, 
the experimental graphs indicate the existence of fewer magnetic cells than the theoretical 
graphs display. Also, Figure 61 demonstrates the possible presence of varying oxygenated 
subfractions of RBCs due to the widespread distribution of the data. The graphs for 
Experiment #2 are below in Figures 62 – 71. Comparing the gaussian curves from 
Experiment #1 to the gaussian curves from Experiment #2, there is a clear pattern seen in 
the magnetic velocities while decreasing the pO2 between these two experiments. Due to 












Figure 62: MATLAB graphs generated for 160 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 63: MATLAB graphs generated for 60 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 64: MATLAB graphs generated for 40 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 65 MATLAB graphs generated for 30 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 66 MATLAB graphs generated for 25 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 67: MATLAB graphs generated for 20 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 68: MATLAB graphs generated for 15 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 69: MATLAB graphs generated for 10 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 70: MATLAB graphs generated for 5 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with 






Figure 71: MATLAB graphs generated for 0.1% O2 oxygenation level in Experiment #2. Top Left: Whole dataset with 





4.3.2 Gaussian Fit Results Compared to the Hill Equation 
 Once each oxygenation level was evaluated through MATLAB, the Gaussian 
coefficients generated for the two clusters, specified by the k-mean clustering method, were 
utilized to create six graphs per experiment. The first graph, Figure 72, is the magnetic 
velocity mode values in mm/s (b gaussian coefficients) versus the partial pressure of O2 for 
Gaussian 1 for Experiment #1, with error bars representing the standard deviation. Figure 
73 is the same plot; however, it represents the values for Gaussian 2. As mentioned before, 
Gaussian 1 is comprised of the clusters with b-values closest to zero, which varied in cluster 
from oxygenation level to oxygenation level. This convention for Gaussian 1 and 2 is 
represented in Figures 72 and 73. Gaussian 1 does not have a b-value higher than about 
1.5x10-3 mm/s, whereas Gaussian 2’s highest b-value was around  3.5x10-3 mm/s. The same 
graphs for Experiment #2 are in Figures 74 and 75. 
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Figure 73: Gaussian 2 magnetophoretic velocity mode for Experiment #1. 
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Figure 75: Gaussian 2 magnetophoretic velocity mode for Experiment #2. 
 
The next graph produced with the MATLAB gaussian coefficients was the 
normalized b-values versus partial pressure of O2, along with the Hill equation curve fitted 
for the experimental data. The fitted curve was generated through the ‘Regression’ option 
within the ‘Data Analysis’ section of Excel to obtain the slope (n) and intercept (k). Also, 
a linear regression of the log(Z) values versus the log(x) values calculated from Equations 
3.10 and 3.13 were made through the ‘Regression’ option. Figures 76 and 77 represent the 
data in Gauss 1 for Experiment #1, while Figures 78 and 79 are the same graphs, but for 
the data within Gauss 2 in Experiment #1. The corresponding graphs for Experiment #2 
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Figure 76: Hill curve for the Gauss 1 data for Experiment #1. Normalized experimental b-values graphed with a fitted Hill 
curve generated by the regression of the experimental values 
 
 
Figure 77: Linear regression of Gauss 1 data for Experiment #1. Regression was completed for the normalized log(Z) and 
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Figure 78: Hill curve for the Gauss 2 data for Experiment #1. Normalized experimental b-values graphed with a fitted Hill 
curve generated by the regression of the experimental values. 
 
 
Figure 79: Linear regression of Gauss 2 data for Experiment #1. Regression was completed for the normalized log(Z) and 
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Figure 80: Hill curve for the Gauss 1 data for Experiment #2. Normalized experimental b-values graphed with a fitted Hill 
curve generated by the regression of the experimental values 
 
 
Figure 81: Linear regression of Gauss 1 data for Experiment #2. Regression was completed for the normalized log(Z) and 

























Partial Pressure of O2, mmHg































Figure 82: Hill curve for the Gauss 2 data for Experiment #2. Normalized experimental b-values graphed with a fitted Hill 
curve generated by the regression of the experimental values. 
 
 
Figure 83: Linear regression of Gauss 2 data for Experiment #2. Regression was completed for the normalized log(Z) and 
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 The specific values from these graphs, which are important in determining whether 
the Hill equation is a representative model for the deoxygenation of RBC experiments, are 
the slope (n) and intercepts (k) for the linear regression graphs, Figures 77, 79, 81, and 83. 
These values for Experiments 1 and 2 are summarized in Table VII below. Compared to 
common practice of setting n = 2.7 in literature, the values obtained through experiments, 
found in Table VII, were on average 65.53% lower. 
Table VII: Regression line information for both Gaussians in Experiments 1 and 2. 
Regression Line Slope and Intercept Information 
Experiment Gaussian Slope, n Intercept, k Slope P Value Intercept P Value 
1 
1 1.77 ± 0.35 -1.76 ± 0.45 9.210-4 4.610-3 
2 0.91 ± 0.55 -0.79 ± 0.76 0.14 0.33 
2 
1 1.53 ± 0.36 -1.8 ± 0.47 2.810-3 5.010-3 
2 1.36 ± 0.41 -1.71 ± 0.58 0.01 0.02 
 
4.4 Results for Glioma Experiments 
 The specific aim for the glioma experiments was to determine the magnetic 
properties of the GL261 cell cultures provided by Dr. Justin Lathia’s lab at the Cleveland 
Clinic, and to validate the CTV data post-processing capabilities utilized in the 
deoxygenation of RBCs. First, the RPMI media was evaluated to determine if it possessed 
any magnetic properties. Then, cytosmears were created to image the cells. Next, the 
magnetophoretic mobility was analyzed through CTV, and lastly, the ability to isolate 
CSCs was explored with MDM. 
To ensure the RPMI media did not present magnetic properties, and the magnetic 
susceptibility was similar to that of water, the mean magnetic susceptibility values 
measured with the MSB-Auto were compared through a t-Test assuming unequal variances 
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for the means. The results from the t-Test between RPMI and MilliQ water are displayed 
in Table VIII and the results from RPMI and distilled water are in Table IX.  
Table VIII: Results of the t-Test between RPMI media and MilliQ water to determine how similar the magnetic 
susceptibilities are between the two with five measurements for each. 
t-Test: Two-Sample Assuming Unequal Variances 
Statistical Parameter χ of RPMI Media  χ of MilliQ Water 
Mean -9.3110-6 -9.3210-6 
t Stat 0.047   
t Critical two-tail 2.57   
 
Table IX: Results of the t-Test between RPMI media and distilled water to determine how similar the magnetic 
susceptibilities are between the two with five measurements for each. 
t-Test: Two-Sample Assuming Unequal Variances 
Statistical Parameter χ of RPMI Media χ of Distilled Water 
Mean -9.3110-6  -9.1010-6 
t Stat -0.73   
t Critical two-tail 2.78   
 
Upon reviewing the results of the statistical analysis, the t-stat value between RPMI and 
MilliQ water is 0.047, which is between the positive and negative values of the t-critical 
two-tail values, -2.571 and 2.571. Also, the t-stat value for RPMI and distilled water,              
-0.726, is between -2.776 and 2.776, t-critical two-tail values. This information indicates 
that the RPMI media does not have magnetic properties. 
 Due to time constraints of this project, none of the PFA fixed slides generated 
through cytospin and MDM were fluorescently stained to be imaged. However, four 
cytosmears created utilizing HEMA fixative were imaged, which are displayed in Figures 
84-87. All the images were taken utilizing the same microscope within the ImageCore at 
the Cleveland Clinic LRI, at the same magnification of 40 with a 15 µm scale bar in the 




Figure 84: Image of GL261 fixed with HEMA solution, imaged at 40 magnification on November 19, 2018. 
 
 





Figure 86: Image of GL261 fixed with HEMA solution, imaged at 40 magnification on December 5, 2018. 
 
 




As mentioned in Section 3.5.2, the procedure for analyzing the CTV results for the glioma 
experiments followed the same procedure as the analysis for the deoxygenation 
experiments. A total of 12 glioma experiments were completed for the GL261 and 3T3 
cultures, and were analyzed with the MATLAB program found in Appendix B. These 12 
experiments were analyzed utilizing the k-mean clustering concept described in Section 
3.4.6 to differentiate bands of cells within a sample. Each experiment was run through the 
MATLAB code two or three times with modifying the code to have the data be split into 
two clusters and three clusters. Results from experiments completed on December 5th and 
20th, 2018 for GL261 are presented below in Figures 88 – 91. As seen in Figures 89 and 
91, the MATLAB code can differentiate between two subsets of cells within a sample. The 
remainder of the results are in Appendix C. 
 






Figure 89: Gaussian plot of the two clusters presented in Figure 88. 
 
 






Figure 91: Gaussian plot of the two clusters presented in Figure 90.  
 
4.5 Results for Temperature Gradient Exploration 
The main purpose of these calculations was to determine if applying a temperature 
gradient to the MDM assembly would enhance RBC magnetic separation. Figure 92 depicts 
the velocity profile, which was calculated from Equation 2.35, and varying the width by 
0.01 mm increments until 0.25 mm, which is the width of the MDM channel. The slowest 
velocity reached about -40.5 µm/s at 0.05 mm from the cold wall and the fastest velocity 




Figure 92: Giddings velocity profile calculated within Excel. 
 
The COMSOL simulations of the velocity profile were completed next. Figure 93 
displays the results from attempt number one described in Section 3.6. The fastest velocity 
was obtained at the outlet, which is the location of the syringe pump, at about 410-5 m/s. 
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Figure 93: Above: Velocity profile through the manifold generated with COMSOL. Below: Pressure contours through the 
manifold with COMSOL. 
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4.6 Discussion for Sm Verification 
 Over 30 experiments were completed to verify the Sm value, utilizing different 
concentrations of Magnevist and varying the position over a wider range and imaging at 
smaller increments. The results presented in Section 4.1 in Figure 38, utilizing the 2.7 µm 
PS particles and a 50/50 mixture of MDM buffer and Magnevist solution, verified the 
location within the FOV with the highest Sm value and the least variability within the FOV 
was positioned about 4.5 mm from the edge of the magnet. This confirmed the position in 
Figure 11. However, when comparing the Sm values experimentally acquired to the model 
value, the experimental value is almost 1.4 times higher. This did not confirm which value 
for Sm should be utilized when completing CTV.  
There are a few discrepancies which could cause the Sm value to be as high as the 
results presented in Figure 38. The major issue could have been with the particle size. 
Equation 2.15 demonstrates that the Sm value and the particle diameter are inversely 
proportional, increasing Sm if the particle diameter is small. Therefore, if there were 
aggregates within the sample solution, causing the particle size to be larger than what was 
reported, then the Sm value would drop significantly. For example, if the diameter was 
actually 4.010-3 mm, then the Sm value would be about 400 T-A/mm
2. Another difference 
could be the Video Savant and ImageView software are not tracking particles, but groups 
of particles. This could be caused by too high of a particle concentration within the sample 
and would cause the magnetophoretic mobility of the particles appear to be greater than 
they actually are. 
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4.7 Discussion for the Spectrophotometer Experiments 
 The spectrum results for wavelengths of 500 – 700 nm in Figure 39 closely 
resemble the theoretical curves of oxyHb and metHb in Figure 17. Also, the characteristics 
described by Winterbourn within her paper at wavelengths 560, 577, and 630 nm were 
closely reflected (Winterbourn, 1990). Upon analysis utilizing Equations 2.32 – 2.34, the 
concentration of oxyHb within the metHb sample was determined to be negligible, along 
with the concentration of metHb found within the oxyHb sample. The concentrations which 
were calculated agree with the spectrum presented in Figure 39 of the results. 
4.8 Discussion for the Deoxygenation of Red Blood Cells 
The results obtained through the MATLAB code and the Hill curve fitting analysis 
both suggest that for Experiments 1 and 2, RBCs behave similarly to the theoretical models 
from a pO2 at 0.1 mmHg to 160 mmHg. Also, for the points below 30 mmHg, the 
magnetophoresis data indicated significant admixtures of partially oxygenated RBCs. 
These results are in agreement with the Hill model, which demonstrates fully oxygenated 
RBCs dominate within the mixture from 160 mmHg until 30-40 mmHg, where partially 
oxygenated RBCs become noticeable. This is displayed in Figure 94 below.  
This work has demonstrated that the current CTV equipment, modified for the 
purpose of the deoxygenation of RBCs, is capable of determining both parameters, n and 
k, that underlie the two-parameter Hill model. The values of those parameters, determined 
by RBC magnetophoresis, are comparable to the literature values for normal blood 
determined spectrophotometrically (Dash, et al., 2016). As stated by Dash, when the Hill 
parameter n is set to 2.7, between oxygen saturation levels of 30% to 98%, Equation 2.27 
is utilized. Any saturation levels above or below this range, the equation is inaccurately 
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applied (Dash, et al., 2016). However, the current CTV equipment and the RBC 
deoxygenation protocols did not provide the highest precision needed for the determination 
of Adair parameters described in Section 2.7. It is technically plausible that such precision 
could be achieved in the future with the further refinement of the CTV high magnetic field 
assembly and more precise control over the RBC deoxygenation process. 
 
Figure 94: Model of Adair’s equation generated in Maple by Dr. Zborowski. Indicates singly-, doubly-, triply-, fully 
oxygenated, and fully deoxygenated RBC behavior at different partial pressures of O2. Graph of the fractional 
concentrations of five hemoglobin-O2 complexes (left axis), and the corresponding hemoglobin-O2 equilibrium curve 
(right axis) as a function of pO2 calculated from the Adair equation. Symbols nB describe the number of heme groups that 
contribute to the paramagnetic dipole moment of the hemoglobin-O2 complex. 
 
Analysis of the Hill curve slope values provide a measure of the cooperative 
binding of O2 to the Fe
2+ ferrous ion, Figure 2. Values of n>1 indicates when one O2 
molecule is bond to the hemoglobin it is easier for the next O2 molecule to bind, positively 
cooperative binding. When n<1, negative cooperative binding occurs, meaning if one O2 
molecule is bond, then then next molecule will have a more difficult time to bind. Lastly, 
for n=1 noncooperative (completely independent) binding exists, therefore, binding is 
independent of the pO2 (Weiss, 1997). From these definitions of n, it was determined that 
134 
 
for both Experiments 1 and 2, there is a slight indication of positive cooperative binding of 
O2 to hemoglobin based on the n values for the fitted gaussian distributions. Based on the 
p-values of the slope and intercepts for the regression lines and the R2 values being below 
0.8, the experimental data is said to be significantly different from the regression line. 
4.9 Discussion for the Glioma Experiments 
  The results for the original scatter plot for the experiment completed on December 
5, 2018, there are two clusters seen in the histograms for the magnetic velocity and the 
sedimentation velocity. When the data was analyzed with the MATLAB code, Figure 89 
displays the two clusters of cells seen in the magnetic velocity histogram in Figure 88. The 
results for the experiment completed on December 20, 2018 has a similar trend with the 
magnetic and sedimentation velocity histograms showing signs of two clusters of cells in 
each, Figure 91. Figures 89 and 91 demonstrate that there is a cluster of cells within the 
sample which are more magnetic than the others in the sample. When looking at the right 
plots in Figures 88 and 90, the clusters which are more magnetic, also sediment out of the 
solution at a slower rate than the less magnetic clusters. Upon reviewing the results of the 
statistical analysis, the t-stat value between RPMI and MilliQ water is 0.047, which is 
between the positive and negative values of the t-critical two-tail values, -2.571 and 2.571. 
Also, the t-stat value for RPMI and distilled water, -0.726, is between -2.776 and 2.776, t-
critical two-tail values. This information indicates that the RPMI media does not have 
magnetic properties. The cytosmears generated provide a reference to compare to the 
MDM slides to determine if the MDM can isolate CSCs from cancer cells.  
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4.10 Discussion for the Temperature Gradient Exploration  
As seen in Section 4.5 in Figure 92, the maximum value obtained for the velocity 
profile created in Excel was large enough to affect the RBC sedimentation by entrainment 
in the falling or rising layer of water in the channel. However, due to limited knowledge of 
how the COMSOL Multiphysics program works, and the limited time allotted to complete 
the modeling, the attempts completed to obtain the velocity profile within the channel were 
not successful. The results presented in Figure 93 of the velocity profile and the pressure 
contours were in the manifold, not the channel. The remainder of the attempts did not 











CONCLUSION AND RECOMMENDATIONS 
5.1 Conclusions and Recommendations: Sm Verification Experiments 
The location from the edge of the magnet which produces the highest magnetic 
energy density gradient (Sm) with the least variation in the magnitude over the FOV for the 
Mk V magnet assembly was confirmed to be 4.5 mm. However, the value for Sm is still in 
question due to the 140% difference from the values obtained through experiments 
compared to the theoretical value generated through software. Therefore, the original value 
of 365 T-A/mm2 will be utilized until further research is completed. 
 In the future, more experiments should be done at the confirmed 4.5 mm distance 
from the edge of the magnet. When completing these studies, it is recommended to change 
the mixture of Magnevist and MDM buffer from 50/50, to 25/75 while keeping the PS 
particles the same. When a lower concentration of Magnevist is utilized, for example 
0.5/99.5 mixture ratio of Magnevist to MDM buffer, the smaller particle would have a 
lower velocity due to the viscous drag force being proportional to velocity of the particle. 
This allows for the Video Savant imaging software to capture the motion of the PS 
particles, without them moving too fast to be tracked. Lastly, decreasing the frame delay 
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would permit for the fast-moving PS particles to be tracked in more images as well as 
capturing the slower-moving particles before they sediment to the bottom of the channel. 
5.2 Conclusions and Recommendations: Spectrophotometry 
 From the results obtained from the spectrophotometry experiments, it was 
concluded that metHb sample was fully converted to metHb, while the oxyHb sample was 
saturated with O2. This demonstrates that spectrophotometry is a reliable reference model 
for RBC magnetophoresis. Recommendations for the future are to complete in process 
testing for the RBC deoxygenation experiments in the spectrophotometer to verify 
Winterbourn’s spectra for oxyHb and deoxyHb (surrogate metHb). 
5.3 Conclusions and Recommendations: Red Blood Cell Deoxygenation Experiments 
The RBC magnetophoretic analysis indicates the fully oxygenated RBCs dominant 
in the sample until the pO2 reaches about 30-40 mmHg. As indicated by the graphs 
generated from Adair’s equation by Dr. Zborowski in Maple, below this point is when the 
partially oxygenated RBC, containing a significant fraction of high-spin hemoglobin, come 
into consideration. These results agree with what is known about cooperative binding 
between the pO2 values of 0 – 30 mmHg, that the fully oxygenated RBCs dominate until 
this range is reached. Therefore, in order to study the RBC sample for its composition in 
partially oxygenated hemoglobin, such a study needs to be focused on the low range of 0-
30 mmHg. These results provided important insights into the opportunities and limitations 
of the new technique of magnetophoretic RBC analysis. This information also confirms the 
hypothesis that the magnetic susceptibility of RBCs does follow the same cooperative 
binding dependence on pO2 as determined spectrophotometrically. 
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The experiments of the deoxygenation of RBCs provided a basis for future studies. 
It is recommended that more research be done for pO2 from 30-0 mmHg to determine if 
singly-, doubly-, triply-, and fully oxygenated and deoxygenated RBCs are able to be 
identified in this region in accordance with the Adair model. When completing future 
experiments, instead of varying the pO2 from 160 mmHg to 0 mmHg as was done for the 
experiments presented in this paper, start with 0 mmHg and go up in oxygenation until 160 
mmHg. Testing blood that was stored for 42 days (from Dr. Mark Yazer at the University 
of Pittsburgh, collaborator on the project) for differences in the RBC magnetically induced 
velocity dependence on pO2 as compared to a freshly drawn blood sample is also a future 
research consideration. Another recommendation for the future, is to use a small amount 
of sample at each pO2 level and test it within the spectrophotometer to confirm 
Winterbourn’s spectra for oxyHb and deoxyHb (surrogate metHb).  
5.4 Conclusions and Recommendations: Glioma Experiments 
 The results from the t-test determined that the mean magnetic susceptibility value 
for RPMI media was not statistically significantly different from the mean values of MilliQ 
water and distilled water. Therefore, it was concluded that the RPMI media does not 
present any magnetic properties which could be passed to the glioma cell causing them to 
be magnetic. 
 The conclusion drawn from the results presented in Section 4.4 about the CTV 
experiments, is that there may be two cell types within the GL261 culture samples provided 
from Soumya in Dr. Lathia’s laboratory, but at this point in time the properties of the cells 
are unknown. To understand these results more, the cytosmears and MDM slides need to 
be fluorescently stained and imaged to determine if CSCs are more magnetic than the other 
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cells present within the sample, and if they are able to be isolated through MDM. Also, it 
is recommended to reanalyze the data through the MATLAB code to confirm the results 
obtained in the experiments presented here. However, the sensitivity of the CTV post-
processing capabilities was validated based on the separation shown in the original scatter 
plots in Figures 88 and 90. 
5.5 Conclusions and Recommendations: Temperature Gradient Exploration 
 The Giddings velocity profile generated in Excel confirmed that introducing a 
temperature gradient to the MDM channel would enhance the magnetic separation of 
RBCs. Therefore, COMSOL modeling progressed to determine a more realistic 
representation of the temperature gradient affects. Due to these results and discussion for 
the COMSOL modeling, no information was provided for the velocity profile within the 
channel. Also, the magnetic properties and the temperature gradient were not introduced 
to the simulation. Therefore, no information was gained by completing these trials within 
COMSOL. In the future it is recommended that someone with experience and knowledge 
of COMSOL Multiphysics completes further exploration of the effects of a temperature 
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APPENDIX A: RELEVANT GRAPHS AND TABLES  
Table X: Common forms of magnetic susceptibility designation, units, and conversion factors (Zborowski, et al., 2016). 
Magnetic Susceptibility Common Forms and Conversion Factors 
Susceptibility 
Designation 
Symbol χ  (CGS units) χ (SI units) 
Conversion factor from 
CGS to SI 
Volume χ 1 1 4π 
Mass/Specific χg cm













4π/106 or 4π/1000, 
respectively 
 
Table XI: Specifications for the Beckman Coulter spectrophotometer (User's guide: DU series 700 UV/Vis scanning 
spectrophotometer, 2012) 
Beckman Coulter DU® 730 Specifications 
Parameter Value Unit 
Operating Mode Transmittance %, Absorbance, Concentration  
Source Lamp Tungsten (visible), Deuterium (UV)  
Wavelength Range 190 - 1100 nm 
Wavelength Accuracy ± 1 in 200 - 900 range nm 
Wavelength Resolution Selectable - 0.1, 0.2, 0.5, 1.0, 2.0, 5.0 nm 
Wavelength Calibration Automatic   
Wavelength Selection Automatic, based on mode selected   
Spectral Bandwidth 3 nm 
Photometric Readout -0.3 - 3.0 A, 0.1 - 100 %T   
Photometric Accuracy ± 0.005 A at 0 A - 0.5 A, 1% at 0.5 A - 2.0 A   
Photometric Linearity <0.5% at 2.0 A, 1% at > 2.0 A   
 
Table XII: Specifications for the Oakton™ Gildmont™ Shielded laboratory Direct-Reading Flowmeter (Oakton™ 
Gilmont™ shielded laboratory direct-reading flowmeters, 2006). 
Oakton™ Gildmont™ Shielded laboratory Direct-Reading Flowmeter Specifications 
Parameter Range Units 
Flow Rate  0.002 - 1.1 mL/min 
Accuracy ± 5 of reading % 
Repeatability ± 1 of reading % 








Table XIII: Specifications for the Bel-Art™ SP Scienceware™ Riteflow™ Mounted Flowmeter (Bel-Art riteflow 
aluminum mounted flowmeter; 150mm scale, size 4, 1998). 
Bel-Art™ SP Scienceware™ Riteflow™ Mounted Flowmeter Specifications 
Parameter Range Units 
Flow Rate 1.1 - 20.4 mL/min 
Accuracy ± 5 of full scale % 
Repeatability ± 0.25 of full scale % 
Maximum Temperature 121 °C 
Maximum Pressure 200 psig 
 
Table XIV: Specifications for the RDO® Rugged DO sensor operated in the deoxygenation vessel for the deoxygenation 
of RBCs experiments (Orion™ RDO™ dissolved oxygen probe, 2008). 
RDO® Rugged Dissolved Oxygen Sensor Specifications 
Parameter Range Units 
Dissolved Oxygen Concentration 0 - 20 mg/L 
Dissolved Oxygen Saturation 0 - 200 % 
Dissolved Oxygen Concentration Accuracy 
±0.1 mg/L up to 8 mg/L mg/L 
±0.2 mg/L up from 8 to 20 mg/L mg/L 
Dissolved Oxygen Concentration Resolution 0.01 mg/L 
Temperature 0 - 50 °C 
Temperature Accuracy ±0.3 °C 
Minimum Immersion Depth 40 mm 
 
Table XV: Dimensions for the RDO® Rugged DO sensor used in the deoxygenation vessel for the deoxygenation of 
RBCs experiments (Orion™ RDO™ dissolved oxygen probe, 2008). 
RDO® Rugged Dissolved Oxygen Sensor Dimensions 
Parameter Value Units 
Sensor Tip Length 70 mm 
Overall Sensor Length 190 mm 
Sensor Tip Diameter 16 mm 










Table XVI: Specifications for the Orion Star A213 DO Benchtop meter utilized for the deoxygenation of RBCs 
experiments (Orion star™ A213 dissolved oxygen benchtop meter, 2015). 
Orion Star A213 DO Benchtop Meter Specifications 
Parameter Range Units 
Concentration 0 - 50 mg/L 
Concentration Resolution 0.01/0.1 mg/L 
Concentration Relative Accuracy 
±0.1 mg/L up to 8 mg/L mg/L 
±0.2 mg/L up from 8 to 20 mg/L mg/L 
Saturation 0 - 500 % 
Saturation Resolution 0.1/1 % 
Saturation Relative Accuracy ±2 % saturation ≤ 200 % % 
Temperature 0 - 50 °C 
Temperature Resolution 0.1 °C 
Temperature Relative Accuracy ±0.1  °C 
 
Table XVII: Specifications and dimensions of the Shandon Cytospin 3 (Cytospin: Cell Preparation System Operator 
Guide, 1997). 
Shandon Cytospin 3 Specifications 
Parameter Value Units 
Operating Speed Range 200 - 2,000 rpm 
Height 215 mm 
Height Clearance 560 mm 
Width 385 mm 
Width Clearance 405 mm 
Depth 495 mm 
Depth Clearance 556 mm 
Weight 18 kg 
 
Table XVIII: Specifications of the Legato 210P multi-syringe pump (Legato 210/210P Syringe Pump, 2016). 
Legato® 210/210P Syringe Pump Specifications 
Parameter Value Units 
Accuracy ± 0.35 % 
Minimum Syringe Size 0.5 µL 
Maximum Syringe Size 140 mL 
Minimum Flow Rate for 0.5 µL Syringe 3.06 pL/min 
Maximum Flow Rate for 140 mL Syringe 215.8 mL/min 
Minimum Step Rate 27.5 sec/µstep 
Maximum Step Rate 26 µsec/µstep 
Minimum Pusher Travel Rate 0.36 µm/min 




APPENDIX B: MATLAB CODE FOR ANALYZING CTV RESULTS – 4/17/2019 
Authors: Robert Royer, Dr. Maciej Zborowski, and Nina Smith 
Select CTV macro file 
Program will pull data from the 'DATA-1' sheet to build plots 
clear 
[file,path] = uigetfile('*.xlsx'); 
cd(path); 
x = xlsread(file,'DATA-1','B:B'); 
y = xlsread(file,'DATA-1','C:C'); 
x = -x;                   %% Magnet is flipped over 
y = -y;                   %% Makes sedimentaion rate below zero 
x1 = x;         % stores gated data 
y1 = y;         % stores gated data 
x2 = x1;        % stores original data 






















Scatter plot with marginal histograms 
Position is defined by [x y xlength ylength] 
position is determined by the bottom-left corner 
binN=10             % average number of histogram counts per bin 
Nbins = floor(lx1/binN)    % number of histogram bins is 1/binN of sample 
size 




figure1 = figure('Name',sprintf('file name is 
%s',file),'NumberTitle','off'); 




% scatplot(x1,y1,'method',radius, N, number of filter coeffs., plot option 
number, marker size) 
% N square grid size, determines number of isolines 
% 'method' = "circles", "squares", or "voronoi" (default) 
% po number = 0 (no plot), 1 (scatter filtered), 2 (scatter & isolines 





pbaspect([1 1 1]); 
xlabel('Magnetic Velocity, mm/s') 





axis([xlimLo xlimHi ylimLo ylimHi]) 
 
colorbar('peer',axes1,'Position',[0.77 0.08 0.01 0.35]) 
 




title(file)           %Changes depending on which file is being run 
 















Histogram for full Set x1 using "histcounts" and "stairs" plot 
clear N edgesN histoN 




histoN=stairs(edgesN(1:length(edgesN)-1),Nx1);    % vector "edges" and "N" 
have to be same length for plotting 
%hold on 
 
K mean clustering analysis. Caution - assigns clusters differently each time it is run. Re-run 
to make sure that the plot displays properly. 
K is the number of clusters in the data 
K     = 2   % Cluster Number 
KMI   = 10                                     % K-means Iteration 






CENTS = F( ceil(rand(K,1)*size(F,1)) ,:);             % Cluster Centers 
DAL   = zeros(size(F,1),K+2);                         % Distances and 
Labels 
CV    = '+r+b+c+m+yorobocomokoysrsbscsmsksy';       % Color Vector 
 
for n = 1:KMI 
for i = 1:size(F,1) 
for j = 1:K   
        DAL(i,j) = norm(F(i,:) - CENTS(j,:));       
      end 
      [Distance, CN] = min(DAL(i,1:K));                % n1:K are Distance 
from Cluster Centers 1:K  
      DAL(i,K+1) = CN;                                % K+1 is Cluster 
Label 





for i = 1:K 
      A = (DAL(:,K+1) == i);                          % Cluster K Points 
      CENTS(i,:) = mean(F(A,:));                      % New Cluster 
Centers 
         NC = find(isnan(CENTS(:,1)) == 1);           % Find Nan Centers 
         for Ind = 1:size(NC,1) 
         CENTS(NC(Ind),:) = F(randi(size(F,1)),:); 









 for i = 1:K 
PT = F(DAL(:,K+1) == i,:);                            % Find points of 
each cluster     
plot(PT(:,1),PT(:,2),CV(2*i-1:2*i),'LineWidth',2);    % Plot points with 
determined color and shape 




xlabel('Magnetic Velocity, mm/s') 





**** Select index "i" for a Cluster selected as Subset B (exluded from Subset A) 
iB=1; 














for i = 1:K 
if i~=iB 
    PT = F(DAL(:,K+1) == i,:);                            % Find points of 
each cluster     
    plot(PT(:,1),PT(:,2),CV(2*i-1:2*i),'LineWidth',2);    % Plot points 
with determined color and shape 
    plot(CENTS(:,1),CENTS(:,2),'*k','LineWidth',7);       % Plot cluster 
centers 
    
text(xlimHi/50+CENTS(i,1),xlimHi/50+CENTS(i,2),num2str(i),'FontSize',20); 




















Scatter plot with marginal histograms for Subset A 
Position is defined by [x y xlength ylength] 
position is determined by the bottom-left corner 
lx1(1)                      % full sample size (w/o outliers) 
binA=lx1a                      % Subset A size 
Nbins(1)                        % full sample histogram bin # 
binXa=binX(1)               % Subset A histogram bin size = full histogram 
bin size 
Abins=abs(floor((max(x1a)-min(x1a))/binXa)) 




CENTS1(1,2)=std(x1a);        % CENTS matrix expanded by addition of SD 
columns 
CENTS1(1,3)=mean(y1a);        % CENTS matrix expanded by addition of SD 
columns 




%figure1 = figure('Name','Figure'); 
figure1 = figure('Name',sprintf('file name is 
%s',file),'NumberTitle','off'); 




% scatplot(x1a,y1a,'method',radius, N, number of filter coeffs., plot 
option number, marker size) 
% N square grid size, determines number of isolines 
% 'method' = "circles", "squares", or "voronoi" (default) 
% po number = 0 (no plot), 1 (scatter filtered), 2 (scatter & isolines 














colorbar('peer',axes1,'Position',[0.77 0.08 0.01 0.35]) 
 


















Scatter plot with marginal histograms for Subset B 
Position is defined by [x y xlength ylength] 
position is determined by the bottom-left corner 
lx1(1)                      % full sample size (w/o outliers) 
binB=lx1b                      % Subset A size 
Nbins(1)                        % full sample histogram bin # 
binXb=binX(1) 
Bbins=abs(floor((max(x1b)-min(x1b))/binXb)) 
CENTS1(2,1)=mean(x1b);        % CENTS matrix expanded by addition of SD 
columns 
CENTS1(2,2)=std(x1b);        % CENTS matrix expanded by addition of SD 
columns 
CENTS1(2,3)=mean(y1b);        % CENTS matrix expanded by addition of SD 
columns 




%figure1 = figure('Name','Figure'); 
figure1 = figure('Name',sprintf('file name is 
%s',file),'NumberTitle','off'); 
 




% scatplot(x1,y1,'method',radius, N, number of filter coeffs., plot option 
number, marker size) 
% N square grid size, determines number of isolines 
% 'method' = "circles", "squares", or "voronoi" (default) 
% po number = 0 (no plot), 1 (scatter filtered), 2 (scatter & isolines 
















colorbar('peer',axes1,'Position',[0.77 0.08 0.01 0.35]) 
 
















Histogram and Gaussian fit for Subset A using "histcounts" and "stairs" plot 
clear N edges histoA 




histoA=stairs(edgesA(1:length(edgesA)-1),NA);    % vector "edges" and "N" 
have to be same length for plotting 
hold on 
Gaussian fit for Subset A 
xG=edgesA(1:length(edgesA)-1).';    % transpose rows to columns 
yG=NA.';    % transpose rows to columns 
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options = fitoptions('gauss1', 'Lower', [0 xlimLo 0], 'Upper', [1000 
xlimHi xlimHi]); 
ff=fit(xG,yG,'gauss1',options) 





Fit parameters for Subset A 





Confidence Intervals for Gaussian peak position fitted to Subset A 




Histogram for Subset B using "histcounts" function and "stairs" plot 
%clear N edges 




histoB=stairs(edgesB(1:length(edgesB)-1),NB);    % vector "edges" and "N" 
have to be same length for plotting 
hold on 
Gaussian fit for Subset B 
xG=edgesB(1:length(edgesB)-1).';    % transpose rows to columns 
yG=NB.';    % transpose rows to columns 
options = fitoptions('gauss1', 'Lower', [0 xlimLo 0], 'Upper', [1000 
xlimHi xlimHi]); 
ff1=fit(xG,yG,'gauss1',options) 





Fit parameters for Subset B 
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Confidence Intervals for Gaussani fit peak position for Subset B 




















Welch's t test (unequal variances and sample sizes) 
N1=binA 
Amean=mean(x1a)  % use mean x1a for t statistic 
Asd=std(x1a)     % use SD x1a for t statistic 
 
N2=binB 
Bmean=mean(x1b)  % use mean x1b for t statistic 
Bsd=std(x1b)     % use SD x1b for t statistic 
 
v = ((Asd^2/N1+Bsd^2/N2))^2/((Asd^4/N1^2/(N1-1)+Bsd^4/N2^2/(N2-1))) 
tval = ((Amean)-(Bmean)) / sqrt((Asd^2/N1+Bsd^2/N2)) 
 




tdist1T = @(t,v) 1-(1-tdist2T(t,v))/2;              % 1-tailed t-
distribution 
tprob = 1-[tdist2T(tval,v)  tdist1T(tval,v)] 
 
Welch's t test CIs of the mean 
alpha=0.05                          % select parameter alpha (significance 
level p) 
fun = @(t) tdist2T(t,v)-(1-alpha);  % function of t alone 
xrange = 1e-6;                      % initial point (or range) for fzero 
procedure 
Subset A CIs of the mean 
alpha 
v=N1-1 




Subset B CIs of the mean 
v=N2-1 









Write to Excel 














colHead = {'xM','SD','yM','SD'}; 
x1Range='B1' 








colHead = {'Gauss coeffs'}; 
x1Range='B1' 








colHead = {'Gauss coeffs'}; 
x1Range='B1' 









































colHead = {'UCLA','LCLA','UCLB','LCLB'}; 
x1Range='B1' 








APPENDIX C: RESULTS GENERATED BY THE MATLAB CODE FOR THE 
GLIOMA EXPERIMENTS  
  
 













Figure 97: MATLAB results generated for 3 clusters the experiment completed by Matt Nagy for a GL261 on August 28, 
2018. 






















Figure 101: MATLAB results generated for 3 clusters the experiment completed for a GL261 on November 30, 2018.  












Figure 103: MATLAB results generated for 2 clusters the experiment completed for a GL261 on January 15, 2019. 
